Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 341031-54-7 Chemical Structure| 341031-54-7

Structure of Sunitinib Malate
CAS No.: 341031-54-7

Chemical Structure| 341031-54-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sunitinib Malate (SU 11248 Malate) is a multi-targeted receptor tyrosine kinase inhibitor with IC50 values of 80 nM for VEGFR2 and 2 nM for PDGFRβ. As an ATP-competitive inhibitor, Sunitinib Malate effectively inhibits Ire1α autophosphorylation and consequent RNase activation.

Synonyms: SU 11248 Malate; Sunitinib (malate); SU11248

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sunitinib Malate

CAS No. :341031-54-7
Formula : C26H33FN4O7
M.W : 532.56
SMILES Code : O=C(C1=C(C)NC(/C=C2C(NC3=C\2C=C(F)C=C3)=O)=C1C)NCCN(CC)CC.O=C(O)[C@@H](O)CC(O)=O
Synonyms :
SU 11248 Malate; Sunitinib (malate); SU11248
MDL No. :MFCD08282795
InChI Key :LBWFXVZLPYTWQI-IPOVEDGCSA-N
Pubchem ID :6456015

Safety of Sunitinib Malate

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H360-H372
Precautionary Statements:P201-P202-P260-P264-P270-P280-P308+P313-P405-P501
Class:6.1
UN#:2811
Packing Group:

Related Pathways of Sunitinib Malate

RTK

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00663559 Carcinoma Renal Cells Phase 2 Completed - Spain ... More >> Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Parc Taulí Sabadell, Barcelona, Spain, 08208 Hospital CLINIC Barcelona, Spain, 08036 Hospital Reina Sofía Córdoba, Spain, 14004 Hospital de Jaén Jaén, Spain, 23007 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT03097601 - Active, not recruiting December 30, 2019 France ... More >> Centre Antoine LACASSAGNE Nice, France, 06189 Less <<
NCT01243359 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage I Renal Cell Cancer Stage II Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Maryland ... More >> Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States, 21287 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00372775 Non-Small Cell Lung Cancer Phase 2 Completed - United States, Connecticut ... More >> Pfizer Investigational Site Norwalk, Connecticut, United States, 06856 United States, Florida Pfizer Investigational Site Cocoa Beach, Florida, United States, 32931 Pfizer Investigational Site Merritt Island, Florida, United States, 32952 Pfizer Investigational Site Titusville, Florida, United States, 32796 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110-1094 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, New Jersey Pfizer Investigational Site Basking Ridge, New Jersey, United States, 07920 United States, New York Pfizer Investigational Site Commack, New York, United States, 11725 Pfizer Investigational Site New York, New York, United States, 10022 United States, Pennsylvania Pfizer Investigational Site Sayre, Pennsylvania, United States, 18840 United States, Texas Pfizer Investigational Site Austin, Texas, United States, 78705 Pfizer Investigational Site Austin, Texas, United States, 78745 Pfizer Investigational Site Austin, Texas, United States, 78758 Pfizer Investigational Site Austin, Texas, United States, 78759 Pfizer Investigational Site Round Rock, Texas, United States, 78664 France Pfizer Investigational Site Pessac, Be1 04495, France, 33604 Pfizer Investigational Site Marseille Cedex 09, France, 13009 Pfizer Investigational Site Saint-Priest en Jarez Cedex, France, 42271 Pfizer Investigational Site Toulouse cedex 9, France, 31059 Italy Pfizer Investigational Site Bologna, Italy, 40139 Pfizer Investigational Site Genova, Italy, 16132 Pfizer Investigational Site Orbassano (TO), Italy, 10043 Pfizer Investigational Site Roma, Italy, 00151 Spain Pfizer Investigational Site Madrid, Spain, 28046 Pfizer Investigational Site Valencia, Spain, 46014 Less <<
NCT00399152 Renal Cancer ... More >>GIST Less << Phase 1 Completed - -
NCT00864864 Glioblastoma ... More >>Brain Tumor Less << Early Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01005472 Metastatic Melanoma Phase 1 Completed - United States, California ... More >> University of California Los Angeles (UCLA) Los Angeles, California, United States, 90095 Less <<
NCT02402062 Neuroendocrine Tumors ... More >> Pancreatic Neoplasms Less << Phase 2 Active, not recruiting June 2019 Spain ... More >> Institut Catalá d'Oncologia L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain, 08907 Hospital Universitario Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Provincial de Castellón Castelló, Valencia, Spain Hospital Universitari Vall d'Hebron Barcelona, Spain, 08035 Hospital Universitario Virgen de las Nieves Granada, Spain, 18014 Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Universitario Virgen de la Victoria Málaga, Spain, 29010 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Less <<
NCT00699374 Carcinoma, Hepatocellular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00699374 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00372775 - Completed - -
NCT00577382 - Completed - -
NCT00577382 Mucosal Lentiginous Melanoma ... More >> Acral Lentiginous Malignant Melanoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Missouri Washington University in St. Louis St. Louis, Missouri, United States, 63110 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37212 Less <<
NCT00422344 Renal Cell Carcinoma ... More >> Kidney Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 Less <<
NCT00961571 Metastatic Colorectal Cancer Phase 2 Terminated(Unanticipated side ... More >>effects and futility) Less << - United States, District of Col... More >>umbia Lombardi Cancer Center at Georgetown University Washington, District of Columbia, United States, 20007 Less <<
NCT01308034 Non GIST Sarcomas Phase 1 Completed - France ... More >> Institut Bergonié Bordeaux, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France, 69373 CHU La Timone Marseille, France Institut de Cancérologie de l'ouest Saint Herblain, France Institut Gustave Roussy Villejuif, France Less <<
NCT00499473 - Completed - -
NCT01462695 Childhood Cerebellar Anaplasti... More >>c Astrocytoma Childhood Cerebral Anaplastic Astrocytoma Childhood Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Less << Phase 2 Completed - -
NCT00499473 Adult Anaplastic Astrocytoma ... More >> Adult Diffuse Astrocytoma Adult Giant Cell Glioblastoma Adult Glioblastoma Adult Gliosarcoma Adult Mixed Glioma Adult Oligodendroglioma Adult Pineal Gland Astrocytoma Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT01462695 - Completed - -
NCT01064310 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00392444 Advanced Malignant Mesotheliom... More >>a Recurrent Malignant Mesothelioma Less << Phase 2 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT01064310 - Completed - -
NCT01402817 Neurofibromatosis ... More >> NF1 Plexiform Neurofibromas Less << Phase 2 Terminated(1 patient died of u... More >>ncertain cause but possibly related to drug.) Less << - United States, Indiana ... More >> Riley Hospital for Children at IU Health Indianapolis, Indiana, United States, 46202 Less <<
NCT03025893 Glioblastoma Multiforme ... More >> Glioblastoma, Adult Glioblastoma Recurrent Brain Tumor GBM Less << Phase 2 Phase 3 Recruiting January 2020 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Netherlands Contact: Cyrillo G Brahm, MD    +31 20 444 4321       Principal Investigator: Henk WM Verheul, MD PhD          Sub-Investigator: Cyrillo G Brahm, MD          University Medical Center Groningen Not yet recruiting Groningen, Netherlands Contact: Cyrillo G Brahm, MD PhD          Principal Investigator: Annemiek ME Walenkamp, MD PhD          Sub-Investigator: Cyrillo G Brahm, MD Less <<
NCT01122615 Renal Cell Cancer ... More >> Kidney Cancer Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02928575 Glioblastoma Multiforme Phase 2 Unknown June 2017 Canada, Alberta ... More >> Tom Baker Cancer Center and University of Calgary Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Jacob Easaw, MD PhD FRCPC    403-521-3446    Jay.Easaw@albertahealthservices.ca    Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Bassam Abdulkarim, MD PhD FRCPC    514-934-1934 ext 43915    bassam.abdulkarim@mcgill.ca Less <<
NCT01158222 Clear Cell Renal Cell Carcinom... More >>a Stage IV Renal Cell Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01158222 - Completed - -
NCT00392444 - Completed - -
NCT00656669 Breast Cancer Not Applicable Completed - United States, Indiana ... More >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00618124 Solid Tumors ... More >>Breast Cancer Neoplasms Less << Phase 1 Completed - United States, Indiana ... More >> Pfizer Investigational Site Indianapolis, Indiana, United States, 46202 United States, New Mexico Pfizer Investigational Site Albuqurque, New Mexico, United States, 87131 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37203 Less <<
NCT00961571 - Terminated(Unanticipated side ... More >>effects and futility) Less << - -
NCT00843037 Paraganglioma ... More >> Pheochromocytoma Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario University Health Network, Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Notre-Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 Netherlands University Medical Centre Groningen Groningen, Netherlands Less <<
NCT00656669 - Completed - -
NCT02164240 Gastrointestinal Stromal Tumor Phase 1 Active, not recruiting May 2020 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00631618 Metastatic Melanoma Phase 2 Completed - United States, California ... More >> California Pacific Medical Center San Francisco, California, United States, 94115 Less <<
NCT00967603 Pancreatic Cancer Phase 2 Completed - Italy ... More >> San Raffaele Scientific Institute Milan, Italy, 20132 Less <<
NCT00299741 Prostate Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel-Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00615446 Solid Tumors Phase 1 Completed - United States, Massachusetts ... More >> Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 Less <<
NCT00299741 - Completed - -
NCT02386111 Carcinoma, Renal Cell ... More >> Kidney Diseases Kidney Neoplasms Urogenital Neoplasms Urologic Diseases Urologic Neoplasms Neoplasms Neoplasms by Histologic Type Clear-cell Metastatic Renal Cell Carcinoma Less << Phase 1 Terminated(Portfolio re-priori... More >>tization) Less << - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California UC Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 UCSF Helen Diller Comprehensive Cancer Center San Francisco, California, United States, 94158 United States, District of Columbia George Washington University-Medical Faculty Associates Washington, District of Columbia, United States, 20037 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Nebraska Nebraska Cancer Specialists Omaha, Nebraska, United States, 68130 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Pennsylvania Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT02058901 Solid Tumors Phase 1 Recruiting December 2017 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Netherlands, 1081HV Contact: Henk MW Verheul, MD, PhD    +31-20-4444321    h.verheul@vumc.nl    Principal Investigator: Henk MW Verheul, MD, PhD Less <<
NCT01740154 - Terminated(Slow Accrual) - -
NCT01402817 - Terminated(1 patient died of u... More >>ncertain cause but possibly related to drug.) Less << - -
NCT00526656 Bladder Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01740154 Fatigue Recur... More >>rent Renal Cell Cancer Stage IV Renal Cell Cancer Less << Not Applicable Terminated(Slow Accrual) - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00787787 Adult Primary Hepatocellular C... More >>arcinoma Advanced Adult Primary Liver Cancer Localized Unresectable Adult Primary Liver Cancer Recurrent Adult Primary Liver Cancer Less << Phase 2 Terminated - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00270413 Metastatic Breast Cancer PHASE2 COMPLETED 2025-03-09 Imelda Bonheiden, Bonheiden, B... More >>elgium|AZ st-jan brugge, Brugge, Belgium|AZ VUB, Brussels, Belgium|UCL, Brussels, Belgium|Charleroi, Charleroi, Belgium|UZ Gent, Gent, 9000, Belgium|ZOL, Hasselt, Belgium|UZ Leuven, Leuven, 3000, Belgium|Liege sart-tilman, Liege, Belgium|Namur st-elisabeth, Namur, Belgium|St-Elisabeth Turnhout, Turnhout, Belgium|AZ st-augustinus, Wilrijk, Belgium|Mont-Godinne, Yvoir, Belgium Less <<
NCT00730353 Esophageal Cancer Phase 2 Completed - United States, Illinois ... More >> Northwestern University Feinberg School of Medicine Chicago, Illinois, United States, 60611 Rush-Presbyterian St. Luke's Medical Center Chicago, Illinois, United States, 60612 Medical & Surgical Specialists, LLC Galesburg, Illinois, United States, 61401 United States, Indiana Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Oncology Hematology Associates of SW Indiana Evansville, Indiana, United States, 47714 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 IN Onc/Hem Associates Indianapolis, Indiana, United States, 46202 Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Arnett Cancer Care Lafayette, Indiana, United States, 47904 Horizon Oncology Center Lafayette, Indiana, United States, 47905 Medical Consultants, P.C. Muncie, Indiana, United States, 47303 Monroe Medical Associates Munster, Indiana, United States, 46321 Northern Indiana Cancer Research Consortium South Bend, Indiana, United States, 46601 Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Ohio Ireland Cancer Center - University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 Less <<
NCT00388037 - Completed - -
NCT00388037 Recurrent Fallopian Tube Cance... More >>r Recurrent Ovarian Epithelial Cancer Recurrent Primary Peritoneal Cavity Cancer Stage IIIA Fallopian Tube Cancer Stage IIIA Ovarian Epithelial Cancer Stage IIIA Primary Peritoneal Cavity Cancer Stage IIIB Fallopian Tube Cancer Stage IIIB Ovarian Epithelial Cancer Stage IIIB Primary Peritoneal Cavity Cancer Stage IIIC Fallopian Tube Cancer Stage IIIC Ovarian Epithelial Cancer Stage IIIC Primary Peritoneal Cavity Cancer Stage IV Fallopian Tube Cancer Stage IV Ovarian Epithelial Cancer Stage IV Primary Peritoneal Cavity Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT01743300 Healthy Phase 1 Completed - -
NCT00753727 Soft Tissue Sarcoma Phase 1 Phase 2 Unknown March 2016 Australia, Victoria ... More >> Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3002 Contact: Ania Matera    +61396563661    Ania.Matera@petermac.org    Contact: Sally Whyte, PhD    +61396563605    sally.whyte@petermac.org    Principal Investigator: David Thomas, MB BS PhD Less <<
NCT00788060 Renal Cell Carcinoma Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27705 Less <<
NCT00768144 - Completed - -
NCT01100177 Glioblastoma Phase 2 Completed - Spain ... More >> Grupo Español de Investigacion en Neurooncologia Madrid, Spain, 28001 Less <<
NCT00787787 - Terminated - -
NCT00329043 Prostate Cancer Phase 2 Active, not recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00730353 - Completed - -
NCT00616109 - Completed - -
NCT00378911 Recurrent Uterine Sarcoma ... More >> Uterine Leiomyosarcoma Less << Phase 2 Completed - United States, Pennsylvania ... More >> Gynecologic Oncology Group Philadelphia, Pennsylvania, United States, 19103 Less <<
NCT00768144 Ovarian Cancer ... More >> Fallopian Tube Cancer Peritoneal Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth-Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT01215578 Neuroendocrine Tumors ... More >> Pancreatic Neoplasms Advanced Disease Sunitinib Less << Phase 2 Terminated(lack of recruitemen... More >>t) Less << - France ... More >> Hôpital Beaujon Clichy, Hauts de Seine, France, 92110 Less <<
NCT00702884 Esophageal Cancer Phase 2 Completed - United States, Ohio ... More >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00813423 Adult Solid Neoplasm Phase 1 Active, not recruiting - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT02919371 Renal Cell Carcinoma Phase 1 Phase 2 Recruiting December 2021 Saudi Arabia ... More >> Oncology Centre, King Faisal Specialist Hospital and Research Centre Recruiting Riyadh, Saudi Arabia, 11211 Contact: Shouki Bazarbashi, MD    00966 11 442 3935    bazarbashi@kfshrc.edu.sa    Contact: Fazal Hussain, MD    966-11-4423949    fhussain@kfshrc.edu.sa Less <<
NCT01824615 Ovarian Cancer ... More >> Adverse Effects Less << Phase 2 Completed - Taiwan ... More >> Cathay General Hospital Taipei, Taiwan, 106 Less <<
NCT00616109 Extensive-Stage Small Cell Lun... More >>g Cancer Less << Phase 2 Completed - United States, Michigan ... More >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00702884 - Completed - -
NCT00793871 Gastrointestinal Neoplasms, Ga... More >>strointestinal Stromal Tumors Less << Phase 4 Completed - China, Jiangsu ... More >> Nanjing Bayi Hospital Nanjing, Jiangsu, China, 210002 China Beijing Cancer Hospital Beijing, China, 100035 307 Hospital of PLA Beijing, China, 100071 Cancer Institute & Hospital Chinese Academy of Medical Sciences and PUMC Bejing, China, 100021 Less <<
NCT00793871 - Completed - -
NCT00459979 Kidney Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00459979 - Completed - -
NCT00910039 Cognitive/Functional Effects ... More >> Metastatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Terminated(Slow Accrual) - United States, Michigan ... More >> Henry Ford Health System Detroit, Michigan, United States, 48202 United States, Ohio Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01827254 - Completed - -
NCT03463460 Thymic Carcinoma Phase 2 Suspended(pending amendment) July 30, 2020 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00890747 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Langerhans Cell Histiocytosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Aggressive NK-cell Leukemia AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Malignancies AIDS-related Small Noncleaved Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma HIV Infection HIV-associated Hodgkin Lymphoma Intraocular Lymphoma Isolated Plasmacytoma of Bone Light Chain Deposition Disease Mast Cell Leukemia Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Osteolytic Lesions of Multiple Myeloma Peripheral T-cell Lymphoma Plasma Cell Neoplasm Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Primary Systemic Amyloidosis Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, California ... More >> Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Washington, District of Columbia, United States, 20057 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, Maryland AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States, 20850 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Missouri Washington University - Jewish Saint Loius, Missouri, United States, 63110 United States, New York Albert Einstein College of Medicine Bronx, New York, United States, 10461 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Pennsylvania Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Less <<
NCT00397787 Acinar Cell Adenocarcinoma of ... More >>the Pancreas Duct Cell Adenocarcinoma of the Pancreas Recurrent Pancreatic Cancer Stage IV Pancreatic Cancer Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00389974 Cervical Adenocarcinoma ... More >> Cervical Adenosquamous Cell Carcinoma Cervical Squamous Cell Carcinoma Recurrent Cervical Cancer Stage IVB Cervical Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> National Cancer Institute of Canada Clinical Trials Group Kingston, Ontario, Canada, K7L 3N6 Less <<
NCT00910039 - Terminated(Slow Accrual) - -
NCT00389974 - Completed - -
NCT00599313 Metastatic Prostate Cancer Phase 2 Completed - -
NCT01827254 - Completed - France ... More >> CHU de la Timone Marseille, Cedex 5, France, 13335 Hopital albert Michalon Grenoble, Cedex 9, France, 38043 Centre Paul Papin Angers, France, 49100 Hôpital Saint-André Bordeaux Cedex, France, 33075 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre Oscar Lambret - Cancérologie Urologie Digestive Lille Cedex, France, 59020 clinique de la Louvière Lille Cedex, France, 59042 Hopital Dupuytren - Oncologie Medicale Limoges Cedex, France, 87042 Centre Leon Berard, Service d'Oncologie Medicale Lyon Cedex 08, France, 69373 Institut Paoli-Calmettes / Hôpital de jour Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Marseille Cedex, France, 13385 Hopital Europeen Georges Pompidou Paris Cedex 15, France, 75908 Centre Eugene Marquis Rennes, France, 35042 CHU Charles Nicolle ROUEN Cedex, France, 76031 Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire Saint Priest en Jarez Cedex, France, 42271 Centre Rene Gauducheau - Service Oncologie Medicale St Herblain Cedex, France, 44805 Institut Claudius Regaud Toulouse, France, 31000 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less <<
NCT00361309 Hepatocellular Carcinoma ... More >> Liver Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00599313 - Completed - -
NCT00519896 Recurrent Thyroid Cancer ... More >> Stage IVA Follicular Thyroid Cancer Stage IVA Papillary Thyroid Cancer Stage IVB Follicular Thyroid Cancer Stage IVB Papillary Thyroid Cancer Stage IVC Follicular Thyroid Cancer Stage IVC Papillary Thyroid Cancer Thyroid Gland Medullary Carcinoma Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00444314 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland Johns Hopkins University School of Medicine Baltimore, Maryland, United States, 21205 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00434109 Neuroendocrine Tumor ... More >> Islet Cell Tumor Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00457743 - Completed - -
NCT00434109 - Completed - -
NCT00457743 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Suita, Osaka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Less <<
NCT00715442 Renal Cell Carcinoma Phase 2 Active, not recruiting June 2020 United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00519896 - Completed - -
NCT01718327 Unresectable and Advanced Chol... More >>angiocarcinoma Less << Phase 2 Completed - France ... More >> Hôpital Beaujon Clichy, France, 92118 Hôpital privé Jean Mermoz Lyon, France, 69008 CHU La Timone Marseille, France, 13005 Hôpital Saint Antoine Paris, France, 75012 Institut Mutualiste Montsouris Paris, France, 75014 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT01498835 Soft Tissue Sarcoma Phase 1 Completed - Germany ... More >> Helios Klinikum Bad Saarow Bad Saarow, Germany, 15526 University Medical Center Mannheim Mannheim, Germany, 68167 Less <<
NCT01286896 Malignant Solid Tumour Phase 1 Unknown December 2011 Netherlands ... More >> The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital Recruiting Amsterdam, Netherlands, 1066CX Contact: Neeltje Steeghs          Principal Investigator: Neeltje Steeghs, MD, PhD Less <<
NCT00979992 - Active, not recruiting - -
NCT00886132 Adenoid Cystic Carcinoma ... More >> Salivary Gland Cancer Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00478426 Endometrial Adenocarcinoma|End... More >>ometrial Endometrioid Adenocarcinoma|Endometrial Serous Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7|Uterine Carcinosarcoma|Uterine Corpus Carcinosarcoma Less << PHASE2 COMPLETED 2019-02-12 Tower Cancer Research Foundati... More >>on, Beverly Hills, California, 90211, United States|City of Hope Comprehensive Cancer Center, Duarte, California, 91010, United States|USC / Norris Comprehensive Cancer Center, Los Angeles, California, 90033, United States|University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States|City of Hope South Pasadena, South Pasadena, California, 91030, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Decatur Memorial Hospital, Decatur, Illinois, 62526, United States|Evanston Hospital CCOP, Evanston, Illinois, 60201, United States|Ingalls Memorial Hospital, Harvey, Illinois, 60426, United States|Joliet Oncology-Hematology Associates Limited, Joliet, Illinois, 60435, United States|Loyola University Medical Center, Maywood, Illinois, 60153, United States|Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States|Central Illinois Hematology Oncology Center, Springfield, Illinois, 62702, United States|Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States|Fort Wayne Medical Oncology and Hematology Inc - Jefferson Boulevard, Fort Wayne, Indiana, 46804, United States|Northern Indiana Cancer Research Consortium, South Bend, Indiana, 46628, United States|University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, 48109, United States|Oncology Care Associates PLLC, Saint Joseph, Michigan, 49085, United States|Mercy Hospital Saint Louis, Saint Louis, Missouri, 63141, United States|Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Cross Cancer Institute, Edmonton, Alberta, T6G 1Z2, Canada|BCCA-Vancouver Cancer Centre, Vancouver, British Columbia, V5Z 4E6, Canada|Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, L8V 5C2, Canada|Kingston Health Sciences Centre, Kingston, Ontario, K7L 2V7, Canada|Ottawa Hospital and Cancer Center-General Campus, Ottawa, Ontario, K1H 8L6, Canada|Odette Cancer Centre- Sunnybrook Health Sciences Centre, Toronto, Ontario, M4N 3M5, Canada|University Health Network-Princess Margaret Hospital, Toronto, Ontario, M5G 2M9, Canada|Jewish General Hospital, Montreal, Quebec, H3T 1E2, Canada Less <<
NCT00338884 Carcinoma, Renal Cell Phase 2 Completed - Argentina ... More >> Pfizer Investigational Site Rosario, Santa Fé, Argentina, (2000) Pfizer Investigational Site Buenos Aires, Argentina, 1431 Pfizer Investigational Site Cordoba, Argentina, X5000AAI Australia, South Australia Pfizer Investigational Site Adelaide, South Australia, Australia, 5000 Australia, Victoria Pfizer Investigational Site Clayton, Victoria, Australia, 3168 Pfizer Investigational Site East Bentleigh, Victoria, Australia, 3165 Brazil Pfizer Investigational Site Porto Alegre, RS, Brazil, 90610-000 Pfizer Investigational Site São Paulo, SP, Brazil, 01308-050 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Mexico Pfizer Investigational Site Guadalajara, Jalisco, Mexico, 44280 Pfizer Investigational Site Monterrey, Nuevo Leon, Mexico, 64460 Taiwan Pfizer Investigational Site Taichung, Taiwan, 407 Pfizer Investigational Site Tainan, Taiwan, 710 Pfizer Investigational Site Taipei, Taiwan, 112 Less <<
NCT00706706 Carcinoma, Renal Cell Phase 4 Completed - China, Guangdong ... More >> Pfizer Investigational Site Guangzhou, Guangdong, China, 510060 China, Hubei Pfizer Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu Pfizer Investigational Site Nanjing, Jiangsu, China, 210002 China Pfizer Investigational Site Beijing, China, 100021 Pfizer Investigational Site Beijing, China, 100034 Pfizer Investigational Site Beijing, China, 100036 Pfizer Investigational Site Chong qing, China, 400038 Pfizer Investigational Site Shanghai, China, 200032 Pfizer Investigational Site Shanghai, China, 200127 Pfizer Investigational Site Tianjin, China, 300060 Pfizer Investigational Site Xi'an, China, 710032 Less <<
NCT03140176 - Recruiting December 30, 2020 Algeria ... More >> Pierre Et Marie Curie Center Recruiting Algers, Algeria, 16005 CAC Annaba Recruiting Annaba, Algeria Hanene Djedi Recruiting Annaba, Algeria Egypt National Cancer Institute Recruiting Cairo, Egypt, 11796 Demerdash Hospital Recruiting Cairo, Egypt Less <<
NCT00979992 Ovarian Clear Cell Adenocarcin... More >>oma Recurrent Ovarian Carcinoma Less << Phase 2 Active, not recruiting - -
NCT00338884 - Completed - -
NCT03109015 Carcinoma, Renal Cell Phase 2 Recruiting May 1, 2019 United States, North Carolina ... More >> Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27705 Contact: Julia Rasmussen    919-681-9822    julia.rasmussen@duke.edu    Contact: Diane Pinder    919-668-8375    diane.pinder@duke.edu    Principal Investigator: Michael Harrison, MD Less <<
NCT02398552 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Unknown March 2017 China, Beijing ... More >> Chinese acadamy of medical science cancer institute & hospital Not yet recruiting Beijing, Beijing, China, 100021 Contact: Changling Li, MD    0086-10-67781331    changllss@yahoo.com.cn    Principal Investigator: Changling Li, MD          Peking University First Hospital Not yet recruiting Beijing, Beijing, China, 100034 Contact: Zhisong He, MD    0086-10-83572211    wyj7074@sohu.com    Principal Investigator: Zhisong He, MD          Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Chuanliang Cui, MD    0086-10-88196951    1008ccl@163.com    Contact: Jun Guo, MD,PHD    0086-10-88196317    guoj307@126.com    Principal Investigator: Jun Guo, MD,PHD          China, Guangdong Sun Yat-sen university cancer center Not yet recruiting Guangzhou, Guangdong, China, 510060 Contact: Fangjian Zhou, MD    0086-20-87343088    zhoufj@sysucc.org.cn    Principal Investigator: Fangjian Zhou, MD          China, Shanghai Cancer Hospital, Fudan University Not yet recruiting Shanghai, Shanghai, China, 200032 Contact: Dingwei Ye, MD    0086-21-64175590    dwye@163.com    Principal Investigator: Dingwei Ye, MD          China, Tianjin Tianjin medical university cancer institute & hospital Not yet recruiting Tianjin, Tianjin, China, 300060 Contact: Xin Yao, MD    0086-22-23340123    yaoxin1969@yahoo.com.cn    Principal Investigator: Xin Yao, MD Less <<
NCT00330564 - Terminated(Slow accrual.) - -
NCT00495625 Liver Cancer PHASE2 TERMINATED 2025-12-10 H. Lee Moffitt Cancer Center &... More >> Research Institute, Tampa, Florida, 33612, United States Less <<
NCT01061411 Clear Cell Sarcoma of the Kidn... More >>ey Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Netherlands Academ Zienkenhuis Bij De University Amsterdam, Netherlands, 1007 MB VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT00330564 Von Hippel-Lindau Syndrome ... More >> Renal Cell Carcinoma Hemangioblastoma Less << Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00495625 Liver Cancer PHASE2 TERMINATED 2025-12-10 H. Lee Moffitt Cancer Center &... More >> Research Institute, Tampa, Florida, 33612, United States Less <<
NCT00706706 - Completed - -
NCT00716820 - Completed - -
NCT00873210 - Completed - Slovakia ... More >> Pfizer Investigational Site Banska Bystrica, Slovakia, 975 17 Pfizer Investigational Site Bojnice, Slovakia, 972 01 Pfizer Investigational Site Bratislava, Slovakia, 812 50 Pfizer Investigational Site Bratislava, Slovakia, 833 10 Pfizer Investigational Site Kosice, Slovakia, 043 91 Pfizer Investigational Site Michalovce, Slovakia, 071 01 Pfizer Investigational Site Nitra, Slovakia, 949 01 Pfizer Investigational Site Poprad, Slovakia, 058 01 Pfizer Investigational Site Presov, Slovakia, 081 81 Pfizer Investigational Site Ruzomberok, Slovakia, 034 26 Pfizer Investigational Site Trebisov, Slovakia, 075 01 Pfizer Investigational Site Trencin, Slovakia, 911 71 Pfizer Investigational Site Trnava, Slovakia, 917 75 Pfizer Investigational Site Zilina, Slovakia, 012 07 Less <<
NCT00716820 - Completed - -
NCT00668811 Papillary Thyroid Cancer ... More >> Follicular Thyroid Cancer Differentiated Thyroid Cancer Less << Phase 2 Completed - United States, District of Col... More >>umbia MedStar Washington Hospital Center Washington, District of Columbia, United States, 20010 Less <<
NCT00668811 - Completed - -
NCT03592199 Clear Cell Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 11, 2022 Brazil ... More >> Instituto do Cancer do Estado de São Paulo Recruiting São Paulo, Brazil, 01246000 Contact: David QB Muniz, MD    +551138932691    david.muniz@hc.fm.usp.br    Contact: Diogo A Bastos, MD    +551138932691    diogo.bastos@hc.fm.usp.br    Principal Investigator: David QB Muniz, MD          Sub-Investigator: Carlos Dzik, MD, PHD          Sub-Investigator: Diogo A Bastos, MD          Sub-Investigator: Jamile A Silva, MD          Sub-Investigator: Pedro HI Velho, MD Less <<
NCT00716625 - Completed - -
NCT00606008 Anaplastic Astrocytoma|Gliobla... More >>stoma Less << PHASE2 COMPLETED 2025-08-12 H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612, United States Less <<
NCT00606008 Anaplastic Astrocytoma|Gliobla... More >>stoma Less << PHASE2 COMPLETED 2025-08-12 H. Lee Moffitt Cancer Center a... More >>nd Research Institute, Tampa, Florida, 33612, United States Less <<
NCT00480935 Renal Cell Carcinoma Phase 2 Terminated(poor recruitment) - Canada, Ontario ... More >> University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00465179 Renal Cell Cancer|Kidney Cance... More >>r Less << PHASE2 COMPLETED 2025-03-15 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00465179 Renal Cell Cancer|Kidney Cance... More >>r Less << PHASE2 COMPLETED 2025-03-15 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00673816 Von Hippel-Lindau Syndrome PHASE1|PHASE2 TERMINATED 2025-02-11 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT00400569 - Completed - -
NCT00864721 Non Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Ocala Oncology Center Ocala, Florida, United States, 34471 Cancer Centers of Florida, P.A. Ocoee, Florida, United States, 34761 United States, Minnesota Minnesota Oncology Hematology, P.A. Minneapolis, Minnesota, United States, 55404 United States, North Carolina Cancer Centers of North Carolina Raleigh, North Carolina, United States, 27607 United States, Oregon Willamette Valley Cancer Institute and Research Center Eugene, Oregon, United States, 97401-8122 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology - Arlington South Arlington, Texas, United States, 76014 Texas Oncology, P.A. - Bedford Bedford, Texas, United States, 76022 Methodist Charlton Cancer Ctr. Dallas, Texas, United States, 75237 Texas Cancer Center of Mesquite Mesquite, Texas, United States, 75150 Texas Oncology Cancer Care and Research Center Waco, Texas, United States, 76712 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Yakima Valley Mem Hosp/North Star Lodge Yakima, Washington, United States, 98902 Less <<
NCT00864721 - Completed - -
NCT00716625 - Completed - -
NCT03066427 Clear Cell Renal Carcinoma Phase 2 Recruiting May 31, 2020 Spain ... More >> ICO Duran i Reynals Recruiting L'Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Xavier García del Muro, MD       garciadelmuro@iconcologia.net    Principal Investigator: Xavier García del Muro, MD          Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Contact: Cristina Suárez, MD    +34 932746000 ext 4919    crsuarez@vhebron.net    Principal Investigator: Cristina Suárez, MD          Hospital Clínic i Provincial de Barcelona Recruiting Barcelona, Spain, 08036 Contact: Oscar Reig, MD    08036 ext 2811    OREIG@clinic.cat    Principal Investigator: Oscar Reig, MD          Complejo Hospitalario Regional Reina Sofía Recruiting Córdoba, Spain, 14004 Contact: María J Méndez, MD    +34 957012408    mjosemv@yahoo.es    Principal Investigator: María J Méndez, MD          Hospital Ramón Y Cajal Recruiting Madrid, Spain, 28034 Contact: Teresa Alonso, MD    +34 913368263    talonso@oncologiahrc.com    Principal Investigator: Teresa Alonso, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Daniel Castellano, MD    +34 913908339    cdanicas@hotmail.com    Principal Investigator: Daniel Castellano, MD Less <<
NCT00400569 Liposarcoma L... More >>eiomyosarcoma Fibrosarcoma Malignant Fibrous Histiocytoma Less << Phase 2 Completed - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01499121 Clear Cell, Metastatic Renal C... More >>ell Carcinoma Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 Kingston General Hospital Research Institute Kingston, Ontario, Canada, K7L 2V7 London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Durham Regional Cancer Centre Oshawa, Ontario, Canada, L1G 2B9 Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 Sunnybrook Health Sciences Centre Toronto, Ontario, Canada, M4N 3M5 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Notre-Dame Hospital Montreal, Quebec, Canada, H2W 1T8 Less <<
NCT00673816 Von Hippel-Lindau Syndrome PHASE1|PHASE2 TERMINATED 2025-02-11 National Institutes of Health ... More >>Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, 20892, United States Less <<
NCT02713763 Pancreatic Neuroendocrine Tumo... More >>ur Metastatic Less << Phase 2 Recruiting July 2019 Spain ... More >> Hospital Universitario Central de Asturias Recruiting Oviedo, Asturias, Spain, 33011 Contact: Paula Jiménez    +34 646662756    palucaji@hotmail.com    Principal Investigator: Paula Jiménez          Hospital Universitario Valle de Hebrón Active, not recruiting Barcelona, Spain, 08035 Hospital Reina Sofía Recruiting Córdoba, Spain, 14004 Contact: Raquel Serrano    +34 957011464    rsblanch@hotmail.com    Principal Investigator: Raquel Serrano          Hospital Universitario Donostia Active, not recruiting Donostia/San Sebastián, Spain, 20014 Hospital Ramón y Cajal Active, not recruiting Madrid, Spain, 28034 Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Rocío García Carbonero    34 91 390 83 39    rgcarbonero@gmail.com    Principal Investigator: Rocio Garcia Carbonero          Hospital General Universitario J.M. Morales Meseguer Active, not recruiting Murcia, Spain, 30008 Complejo Hospitalario Regional Virgen Del Rocío Recruiting Sevilla, Spain, 41013 Contact: Marta Benavent       martabenavent.v@gmail.com    Principal Investigator: Marta Benavent          Instituto Valenciano de Oncología Active, not recruiting Valencia, Spain, 46009 Less <<
NCT00794950 Urinary Tract Urothelial Carci... More >>noma Less << Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Mark P. Schoenberg, MD Baltimore, Maryland, United States, 21287-2101 United States, Michigan Alon Weizer, MD Ann Arbor, Michigan, United States, 48109 Less <<
NCT03449173 Type B3 Thymoma ... More >> Thymic Carcinoma Less << Phase 2 Recruiting March 2, 2021 Italy ... More >> National Cancer Institute Recruiting Milan, Italy, 20133 Less <<
NCT01073644 - Terminated(The study was prema... More >>turely discontinued due to poor recruitment on 18th April 2013. There were no safety concerns that led to the decision to terminate.) Less << - Philippines ... More >> Chong Hua Hospital Cebu City, Philippines Private Clinic Manila, Philippines Less <<
NCT00672594 Prostate Cancer|Prostatectomy PHASE2 COMPLETED 2025-09-13 Duke University Medical Center... More >>, Durham, North Carolina, 27710, United States|MD Anderson, University of Texas, Houston, Texas, 77030, United States Less <<
NCT00672594 Prostate Cancer|Prostatectomy PHASE2 COMPLETED 2025-09-13 Duke University Medical Center... More >>, Durham, North Carolina, 27710, United States|MD Anderson, University of Texas, Houston, Texas, 77030, United States Less <<
NCT02626754 Renal Cell Carcinoma Phase 2 Terminated(In most sites had d... More >>ifficult to recruitting subjects.) Less << - Taiwan ... More >> Kaohsiung Medical University Chung-HO Memorial Hospital Kaohsiung, Taiwan, 80756 Kaohsiung Veterans General Hospital Kaohsiung, Taiwan, 81362 Taichung Veterans General Hospital Taichung, Taiwan, 40705 National Taiwan University Hospital Taipei, Taiwan, 10002 Taipei Vterans General Hospital Taipei, Taiwan, 11217 Tri-Service General Hospital Taipei, Taiwan, 11490 Chang Gung Memorial Hospital, Linkou Taoyuan City, Taiwan, 333 Less <<
NCT00912912 Genitourinary Disease PHASE2 TERMINATED 2025-12-14 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT00912912 Genitourinary Disease PHASE2 TERMINATED 2025-12-14 University of Texas MD Anderso... More >>n Cancer Center, Houston, Texas, 77030, United States Less <<
NCT02072031 Anlotinib RCC Phase 2 Unknown December 2016 China, Beijing ... More >> Peking Union Medical College Hospital Beijing, Beijing, China, 100005 Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Chongqing Chongqing Cancer Hospital Chongqing, Chongqing, China, 404100 China, Gansu Gansu Province Tumor Hospital Lanzhou, Gansu, China, 730050 China, Guangdong Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China, 510000 China, Guangxi Guangxi medical university affiliated tumor hospital Nanning, Guangxi, China, 530021 China, Heilongjiang Harbin medical university affiliated tumor hospital Haerbin, Heilongjiang, China, 150000 China, Jiangsu The 81st Hospital of Chinese PLA Nanjing, Jiangsu, China, 210000 China, Jilin Jilin Cancer Hospital Changchun, Jilin, China, 132000 China, Liaoning China General Hospital of Shenyang Military Region Shenyang, Liaoning, China, 110000 Liaoning Province Tumor Hospital Shenyang, Liaoning, China, 110042 China, Shandong Qilu Hospital,Shandong University Jinan, Shandong, China, 250012 China, Shanghai Cancer Hospital of Fudan University Shanghai, Shanghai, China, 200000 China, Sichuan West China Hospital,Sichuan University Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Medical University Cancer Hospital Tianjin, Tianjin, China, 300000 Less <<
NCT02790580 Breast Cancer Phase 2 Recruiting November 2020 Singapore ... More >> National University Hospital, Singapore Recruiting Singapore, Singapore, 119228 Contact: Soo Chin Lee    (65) 6779 5555    soo_chin_lee@nuhs.edu.sg Less <<
NCT01391130 Metastatic Clear Cell Renal Ce... More >>ll Carcinoma Less << Phase 2 Terminated(Study Terminated du... More >>e to Insufficient Efficacy) Less << - -
NCT00943839 Kidney Cancer Not Applicable Completed - France ... More >> Centre Antoine Lacassagne Nice, France, 06189 Less <<
NCT00847015 Bladder Cancer ... More >> Urinary Bladder Less << Phase 2 Completed - United States, New Jersey ... More >> Memorial Sloan-Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center at Mercy Medical Center Rockville Centre, New York, United States, 11570 Memoral Sloan Kettering Cancer Center@Phelps Sleepy Hollow, New York, United States Less <<
NCT03456401 Renal Cancer Cell Phase 2 Terminated(availability of new... More >> and more promising therapeutic agents than expected in the experimentation in question) Less << - Italy ... More >> Istituto Tumori Milan, Mi, Italy, 20156 Less <<
NCT00847015 - Completed - -
NCT00583063 Solid Tumors Early Phase 1 Completed - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00859456 Sarcoma, Soft Tissue Phase 2 Unknown December 2013 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00361244 Colorectal Carcinoma Phase 1 Phase 2 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01019798 Non Small Cell Lung Cancer Phase 2 Unknown December 2011 Taiwan ... More >> Section of Hematology, Department of Medicine,Taipei Medical University Hospital Recruiting Taipei, Taiwan, 110 Contact: Cheng-Jeng Tai, M.D.    886-2-27372181 ext 3903    cjtai@tmu.edu.tw    Principal Investigator: Cheng-Jeng Tai, M.D. Less <<
NCT01616186 Locally Metastatic Malignant N... More >>eoplasm Less << Phase 2 Withdrawn April 2016 -
NCT01026337 Renal Cell Carcinoma ... More >> Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Not Applicable Active, not recruiting - United States, Pennsylvania ... More >> Abramson Cancer Center of The University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00482911 Intraocular Melanoma ... More >> Malignant Conjunctival Neoplasm Less << Phase 2 Terminated(Investigator left t... More >>he institute.) Less << - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00720941 - Active, not recruiting - -
NCT00720941 Carcinoma, Renal Cell Phase 3 Active, not recruiting June 30, 2019 -
NCT00482911 - Terminated(Investigator left t... More >>he institute.) Less << - -
NCT00089648 - Completed - -
NCT00678119 Renal Cell Carcinoma Phase 2 Completed - United States, California ... More >> City of Hope Duarte, California, United States, 91010 UCLA Los Angeles, California, United States, 90095 United States, Colorado The Urology Center of Colorado Denver, Colorado, United States, 80211 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Indiana The Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kansas University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, Minnesota University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 United States, North Carolina Carolina's Medical Center / Blumenthal Cancer Center Charlotte, North Carolina, United States, 28204 United States, Ohio Barrett Cancer Cincinnati, Ohio, United States, 45267 United States, Texas CORTPA Dallas, Texas, United States, 75230 United States, Virginia Urology of Virginia-Sentara Medical Group Norfolk, Virginia, United States, 23502 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less <<
NCT00662025 Advanced/Metastatic Breast Can... More >>cer Less << Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Anjo-city, Aichi, Japan Pfizer Investigational Site Nagoya, Aichi, Japan Pfizer Investigational Site Okazaki-City, Aichi, Japan Pfizer Investigational Site Toyoake, Aichi, Japan Pfizer Investigational Site Matsuyama-shi, Ehime, Japan Pfizer Investigational Site Kure, Hiroshima, Japan Pfizer Investigational Site Morioka, Iwate, Japan Pfizer Investigational Site Yokohama, Kanagawa, Japan Pfizer Investigational Site Sakai, Osaka, Japan Pfizer Investigational Site Bunkyo-ku, Tokyo, Japan Pfizer Investigational Site Koto-ku, Tokyo, Japan Pfizer Investigational Site Chiba, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Kagoshima, Japan Pfizer Investigational Site Kyoto, Japan Pfizer Investigational Site Niigata, Japan Pfizer Investigational Site Osaka, Japan Less <<
NCT00890110 Renal Cell Cancer Phase 1 Phase 2 Unknown December 2011 -
NCT00089648 Carcinoma, Renal Cell Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Duarte, California, United States, 91010 Pfizer Investigational Site Pasadena, California, United States, 91105 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60637-1460 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27710 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232-5536 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT03249740 Neovascular Age-Related Macula... More >>r Degeneration Less << Phase 1 Phase 2 Recruiting March 2020 United States, Arizona ... More >> Retinal Consultants of Arizona Recruiting Gilbert, Arizona, United States, 85296 Contact: Elisa Martinez    602-222-2221 ext 4115    emartinez@retinalconsultantsaz.com    United States, California Retina Institute of California Recruiting Arcadia, California, United States, 91007 Contact: Valentina Bozikovic    626-574-0188    vbozikovic@retina2020.com    Retina-Vitreous Associates Medical Group Recruiting Beverly Hills, California, United States, 90211 Contact: Janet Kurokouch    310-289-2478 ext 1243    jkurokouchi@laretina.com    United States, Florida Retina Macula Specialists of Miami, LLC Withdrawn Miami, Florida, United States, 33126 United States, Indiana Midwest Eye Institute Recruiting Indianapolis, Indiana, United States, 46290 Contact: Cari Novak    317-805-4596    cari.novak@gmail.com    United States, New York Ophthalmic Consultants of Long Island Recruiting Lynbrook, New York, United States, 11563 Contact: Isabel Lezcano    516-593-4026    ilezcano@ocli.net    United States, Texas Retina Research Institute of Texas Recruiting Abilene, Texas, United States, 79606 Contact: Courtney Wheeler    325-690-4414    Courtney.Wheeler@txicr.clinic    Texas Retina Associates Recruiting Arlington, Texas, United States, 76012 Contact: Michelle Curry    682-433-5457    mcurry@texasretina.com    Retina Research Center, PLLC Recruiting Austin, Texas, United States, 78705 Contact: Ivana Gunderson    512-279-1251    igunderson@e-retina.net    Medical Center Ophthalmology Associates Recruiting San Antonio, Texas, United States, 78240 Contact: Beatrice Guajardo    210-697-2036 ext 2245    bguajardo@mcoaeyecare.com Less <<
NCT00662025 - Completed - -
NCT02231749 Advanced Renal Cell Carcinoma ... More >> Metastatic Renal Cell Carcinoma Less << Phase 3 Active, not recruiting September 30, 2019 -
NCT01711268 - Unknown December 2014 Australia, New South Wales ... More >> Crown Princess Mary Cancer Centre, Westmead Hospital Recruiting Westmead, New South Wales, Australia, 2145 Contact: Howard Gurney, MBBS (Hon), FRACP    +61298455200    howard.gurney@sydney.edu.au    Principal Investigator: Howard Gurney, MBBS (Hon), FRACP Less <<
NCT00443534 Neoplasms Not Applicable Completed - -
NCT00573404 Gastrointestinal Stromal Tumor Phase 1 Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00443534 - Completed - -
NCT01225848 Urothelial Carcinoma Phase 2 Completed - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01784978 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Lack of recruitment... More >>) Less << - France ... More >> Hopital Bordeaux University Bordeaux, France Greece ALEXANDRA General Hospital of Athens Athens, Greece, 11528 Spain Hospital Universitario Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital del Mar Barcelona, Spain, 08003 Hospital Universitario 12 de Octubre Madrid, Spain, 28026 Hospital Clínico San Carlos Madrid, Spain, 28040 Clara Campal. Hospital Sanchinarro Madrid, Spain, 28050 Hospital Universitario Virgen de la Victoria Málaga, Spain Hospital General Universitario de Valencia Valencia, Spain Less <<
NCT00620347 Lung Cancer Phase 2 Completed - Korea, Republic of ... More >> National Cancer Center, Korea Goyang-si, Gyeonggi-do, Korea, Republic of, 411-764 Less <<
NCT00265317 Carcinoma, Non-Small-Cell Lung Phase 2 Completed - -
NCT02231749 - Active, not recruiting - -
NCT01265901 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT00609622 Colorectal Neoplasms Phase 2 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00555256 Non-Small Cell Lung Cancer Phase 1 Completed - United States, Missouri ... More >> Washington University School of medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01829217 Lung Cancer Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00609622 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01829217 - Completed - -
NCT00265317 - Completed - -
NCT01033981 - Terminated(See termination rea... More >>son in detailed description.) Less << - Panama ... More >> Pfizer Investigational Site Panama City, Panama Less <<
NCT00400114 Esophageal Cancer Phase 2 Completed - Canada, Ontario ... More >> The Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada, K1H 8L6 University Health Network (Princess Margaret & Toronto General Hospitals) Toronto, Ontario, Canada, M5G 2C4 Less <<
NCT01118039 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer Less << Phase 2 Unknown - Spain ... More >> Hospital Del Mar Recruiting Barcelona, Spain, 08003 Contact: Contact Person    34-39-3248-3861    XVillanueva@imas.imim.es    Hospital de la Santa Cruz i Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Contact Person    34-93-553-7118    jmaroto@santpau.cat    Hospital Universitario San Carlos Recruiting Madrid, Spain, 28040 Contact: Contact Person    34-91-330-3000, Ext. 7935    jgonzalezl.hcsc@salud.madrid.org    Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact: Contact Person    34-91-469-2313    cdanicas@hotmail.com Less <<
NCT00474994 Adult Malignant Fibrous Histio... More >>cytoma of Bone Desmoid Tumor Endometrial Cancer Ovarian Cancer Sarcoma Small Intestine Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT02853331 Renal Cell Carcinoma Phase 3 Active, not recruiting January 27, 2020 -
NCT00474994 - Completed - -
NCT00887575 Breast Cancer Phase 1 Phase 2 Completed - United States, Florida ... More >> Holy Cross Hospital Ft. Lauderdale, Florida, United States, 33308 Florida Cancer Specialists North Ft. Myers, Florida, United States, 33916 Florida Cancer Specialists South Ft. Myers, Florida, United States, 33916 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska Nebraska Methodist Cancer Center Omaha, Nebraska, United States, 68114 United States, New Jersey Hematology Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Oklahoma Cancer Centers of Southwest Oklahoma Lawton, Oklahoma, United States, 73505 United States, Tennessee Family Cancer Center Collierville, Tennessee, United States, 38017 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT00887575 - Completed - -
NCT00524316 Liver Cancer Phase 2 Terminated(low accrual) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00077974 Carcinoma, Renal Cell Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Duarte, California, United States, 91010-3000 Pfizer Investigational Site Pasadena, California, United States, 91105 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 United States, Michigan Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, Minnesota Pfizer Investigational Site Rochester, Minnesota, United States, 55905 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 Pfizer Investigational Site New York, New York, United States, 10022 United States, North Carolina Pfizer Investigational Site Durham, North Carolina, United States, 27705 United States, Ohio Pfizer Investigational Site Cleveland, Ohio, United States, 44195 United States, Oregon Pfizer Investigational Site Portland, Oregon, United States, 97213 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT00387920 Central Nervous System Metasta... More >>ses Childhood Central Nervous System Choriocarcinoma Childhood Central Nervous System Embryonal Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Central Nervous System Germinoma Childhood Central Nervous System Mixed Germ Cell Tumor Childhood Central Nervous System Teratoma Childhood Central Nervous System Yolk Sac Tumor Recurrent Childhood Central Nervous System Embryonal Tumor Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, California Childrens Hospital of Orange County Orange, California, United States, 92868-3874 UCSF-Mount Zion San Francisco, California, United States, 94115 University of California San Francisco Medical Center-Parnassus San Francisco, California, United States, 94143 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States, 15224 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Baylor College of Medicine Houston, Texas, United States, 77030 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Canada, Quebec Centre Hospitalier Universitaire Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Less <<
NCT00077974 - Completed - -
NCT00373113 Breast Neoplasms Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT02420821 - Active, not recruiting - -
NCT00747305 Kidney Cancer Phase 1 Terminated(Study terminated ea... More >>rly due to low accrual.) Less << - United States, South Carolina ... More >> Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT02420821 Renal Cell Carcinoma Phase 3 Active, not recruiting December 1, 2021 -
NCT01803503 Solid Tumors ... More >>Breast Cancer Non-small Cell Lung Cancer Prostate Cancer Gastric Cancer Less << Phase 2 Unknown April 2018 Singapore ... More >> National University Hospital Not yet recruiting Singapore, Singapore, 119074 Contact: Soo Chin Lee, MBBS    (65) 6779 5555    soo_chin_lee@nuhs.edu.sg    Principal Investigator: Soo Chin Lee, MBBS          National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Soo Chin Lee, MBBS    +65 6779 5555    soo_chin_lee@nuhs.edu.sg    Principal Investigator: Soo Chin Lee, MBBS Less <<
NCT00668863 Unresectable or Metastatic Col... More >>orectal Cancer Less << Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Nagoya, Aichi, Japan Pfizer Investigational Site Chiba-shi, Chiba-ken, Japan Pfizer Investigational Site Matsuyama-shi, Ehime, Japan Pfizer Investigational Site Sapporo-shi, Hokkaido, Japan Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Kochi-shi, Kochi, Japan Pfizer Investigational Site Saku, Nagano, Japan Pfizer Investigational Site Osakasayama-shi, Osaka, Japan Pfizer Investigational Site Takatsuki, Osaka, Japan Pfizer Investigational Site Shimotsuke-shi, Tochigi, Japan Pfizer Investigational Site Minoh/Osaka, Japan Less <<
NCT00879619 - Terminated(Terminated due to s... More >>low accrual.) Less << - -
NCT00373113 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00524316 - Terminated(low accrual) - -
NCT00668863 - Completed - -
NCT00879619 Prostate Cancer ... More >> Adenocarcinoma of the Prostate Recurrent Prostate Cancer Stage I Prostate Cancer Stage III Prostate Cancer Stage IV Prostate Cancer Less << Phase 1 Phase 2 Terminated(Terminated due to s... More >>low accrual.) Less << - United States, California ... More >> Chao Comprehensive Cancer Center Orange, California, United States, 92868 Less <<
NCT00930033 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Active, not recruiting February 2020 France ... More >> Hopital Necker Paris, France, 75015 Less <<
NCT01070186 Renal Cell Carcinoma Phase 2 Withdrawn(No participants were... More >> enrolled.) Less << - -
NCT00372567 Gastrointestinal Stromal Tumor Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, Michigan ... More >> Pfizer Investigational Site Detroit, Michigan, United States, 48201 Pfizer Investigational Site Farmington Hills, Michigan, United States, 48334 United States, Missouri Pfizer Investigational Site Creve Coeur, Missouri, United States, 63141 Pfizer Investigational Site St. Louis, Missouri, United States, 63110 Pfizer Investigational Site St. Peters, Missouri, United States, 63376 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 Germany Pfizer Investigational Site Goettingen, Germany, 37075 Pfizer Investigational Site Hamburg, Germany, 22767 Hong Kong Pfizer Investigational Site Lai Chi Kok, Kowloon, Hong Kong, 0 Pfizer Investigational Site Tuen Mun, New Territories, Hong Kong, 0 Pfizer Investigational Site Hong Kong, Hong Kong, 0 Italy Pfizer Investigational Site Bologna, Italy, 40138 Pfizer Investigational Site Milano, Italy, 20133 Pfizer Investigational Site San Giovanni Rotondo, Italy, 71013 Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Spain Pfizer Investigational Site Barcelona, Spain, 08036 Pfizer Investigational Site Valencia, Spain, 46009 United Kingdom Pfizer Investigational Site Glasgow, United Kingdom, G12 0YH Pfizer Investigational Site Leeds, United Kingdom, LS9 7TF Pfizer Investigational Site London, United Kingdom, NW1 2PG Pfizer Investigational Site London, United Kingdom, SW3 6JJ Pfizer Investigational Site London, United Kingdom, W1 Pfizer Investigational Site Manchester, United Kingdom, M20 4BX Less <<
NCT00372567 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00496223 Melanoma Phase 1 Phase 2 Terminated(toxicities required... More >> dose reduction compromising effectiveness and PI left Moffitt) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00905021 Metastatic Breast Cancer Phase 1 Phase 2 Terminated(Sponsor withdrew su... More >>pport) Less << - United States, Texas ... More >> Baylor College of Medicine, Lester and Sue Smith Breast Center Houston, Texas, United States, 77030 Less <<
NCT00798889 Solid Tumors Not Applicable Completed - -
NCT00453895 Adrenocortical Carcinoma Phase 2 Unknown June 2011 Germany ... More >> Charite Berlin Berlin, Germany Dept. of Medicine I, University of Wuerzburg Wuerzburg, Germany, 97080 Less <<
NCT00499135 Adult Solid Neoplasm ... More >> Clear Cell Renal Cell Carcinoma Recurrent Renal Cell Carcinoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT00824538 Breast Cancer Phase 2 Terminated(Closed prematurely ... More >>due to emerging data on toxicity and competing trials.) Less << - -
NCT00905021 - Terminated(Sponsor withdrew su... More >>pport) Less << - -
NCT00853125 Kidney Cancer Phase 2 Terminated(Slow accrual) - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00720148 Solid Tumors Phase 1 Completed - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00695292 Small Cell Lung Cancer Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Florida Hospital Cancer Insitute Orlando, Florida, United States, 32804 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Louisiana Baton Rouge General Medical Center Baton Rouge, Louisiana, United States, 70806 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00798889 - Completed - -
NCT00524186 Esophageal Cancer ... More >> Gastric Cancer Less << Phase 1 Terminated(PI left institute) - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00695292 - Completed - -
NCT01238055 Advanced Gastric Cancer Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT02555748 Metastatic Renal Cell Cancer Phase 4 Recruiting June 2021 France ... More >> CHU DE BORDEAUX - Hôpital Saint-André Recruiting Bordeaux, France, 33035 Contact: Marine GROSS-GOUPIL, MD    + 33 (0)5 56 79 58 08    marine.gross-goupil@chu-bordeaux.fr    Principal Investigator: Marine GROSS-GOUPIL, MD          Institut Bergonie Recruiting Bordeaux, France, 33076 Contact: Guilhem ROUBAUD, MD    + 33 (0)5 56 33 33 41    g.roubaud@bordeaux.unicancer.fr    Principal Investigator: Guilhem ROUBAUD, MD          CHU DE LIMOGES - Hôpital Dupuytren Recruiting Limoges, France, 87042 Contact: Sabrina FALKOWSKI, MD    + 33 (0)5 55 05 61 00    sabrina.falkowski@chu-limoges.fr    Principal Investigator: Sabrina FALKOWSKI, MD          Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Helen BOYLE, MD    +33 (0)4 78 78 28 28    helen.boyle@lyon.unicancer.fr    Principal Investigator: Aude FLECHON, MD          Institut Paoli Calmettes Recruiting Marseille, France, 13273 Contact: Gwénaëlle GRAVIS-MESCAM, MD    + 33 (0)4 91 22 36 77    gravisg@ipc.unicancer.fr    Principal Investigator: Gwénaëlle GRAVIS-MESCAM, MD          Institut Regional Du Cancer Montpellier Recruiting Montpellier, France, 34298 Contact: Diego TOSI, MD    + 33 (0)4 67 61 23 04    diego.tosi@icm.unicancer.fr    Principal Investigator: Diego TOSI, MD          CH RODEZ Recruiting Rodez, France, 12027 Contact: Guillermo REYES ORTEGA, MD    05 65 55 22 10    g.reyes-ortega@ch-rodez.fr    Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD    + 33 5 31 15 51 03    Chevreau.christine@iuct-oncopole.fr    Principal Investigator: Christine CHEVREAU, MD          Gustave Roussy Withdrawn Villejuif, France, 94805 Less <<
NCT01098903 - Completed - Australia, New South Wales ... More >> Westmead Hospital Westmead, New South Wales, Australia, 2145 Netherlands Academic medical center Amsterdam Amsterdam, Netherlands, 1105AZ Erasmus Medical Center, Daniel Den Hoed Cancer Center Rotterdam, Netherlands, 3075EA Less <<
NCT00824538 - Terminated(Closed prematurely ... More >>due to emerging data on toxicity and competing trials.) Less << - -
NCT00462982 - Completed - -
NCT00729833 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00462982 Kidney Cancer ... More >> Melanoma (Skin) Metastatic Cancer Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00729833 Advanced Cancer ... More >> Advanced Solid Tumors Less << Phase 1 Terminated(See termination rea... More >>son in detailed description.) Less << - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Santa Monica, California, United States, 90404 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site San Antonio, Texas, United States, 78229 Less <<
NCT00849186 Kidney Cancer Not Applicable Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00891878 - Completed - -
NCT00891878 Adenocarcinoma of the Gastroes... More >>ophageal Junction Esophageal Cancer Less << Phase 2 Completed - -
NCT00698815 Recurrent Non-Small Cell Lung ... More >>Carcinoma Stage IIIB Non-Small Cell Lung Cancer AJCC v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Less << Phase 2 Completed - -
NCT00372424 Breast Cancer Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1000 Pfizer Investigational Site Bruxelles, Belgium, 1200 Pfizer Investigational Site Charleroi, Belgium, 6000 Pfizer Investigational Site Sint-Niklaas, Belgium, 9100 Pfizer Investigational Site Wilrijk, Belgium, 2610 Italy Pfizer Investigational Site Meldola, FC, Italy, 47014 Pfizer Investigational Site Milano, Italy, 20132 Less <<
NCT00408252 Recurrent Disease ... More >> Squamous Cell Head and Neck Carcinoma Palliative Treatment Less << Phase 2 Terminated(Too frequent grade ... More >>3-4 toxicities) Less << - Belgium ... More >> Cliniques Universiatires St LUC UCL Bruxelles, Belgium, 1200 clinique Sainte Elisabeth Namur, Belgium, 5000 Clinique universiataire de Mont Godinnes UCL Yvoir, Belgium, 5004 France Centre Jean Perrin Clermont Ferrand, France, 263011 Centre G-f Leclerc DIJON Cedex, France, 8021079 Centre Alexis Vautrin Nancy, France, 4511 René Gauducheau Saint Herblain Cedex, France, 44805 CHU Bretonneau Tours cedex 1, France, 37044 Institut Gustave Roussy Villejuif Cedex, France, 94805 Less <<
NCT00698815 - Completed - -
NCT01147822 Carcinoma, Renal Cell Phase 2 Active, not recruiting September 30, 2019 China, Guangdong ... More >> Novartis Investigative Site Guangzhou, Guangdong, China, 510060 China, Jiangsu Novartis Investigative Site Nanjing, Jiangsu, China, 210002 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Beijing, China, 100036 Novartis Investigative Site Beijing, China, 100853 Novartis Investigative Site Beijing, China Novartis Investigative Site Shanghai, China, 200032 Novartis Investigative Site Shanghai, China, 200127 Novartis Investigative Site Tianjin, China, 300060 Korea, Republic of Novartis Investigative Site Daejeon, Korea, Republic of, 301-721 Novartis Investigative Site Goyang-si, Gyeonggi-Do, Korea, Republic of, 410-769 Novartis Investigative Site Seoul, Korea, Republic of, 120-752 Novartis Investigative Site Seoul, Korea, Republic of, 135-710 Novartis Investigative Site Seoul, Korea, Republic of, 138-736 Taiwan Novartis Investigative Site Kaohsiung Hsien, Taiwan, 833 Novartis Investigative Site Taichung, Taiwan, 40402 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Novartis Investigative Site Taipei, Taiwan, 11217 Novartis Investigative Site Taoyuan County, Taiwan, 333 Less <<
NCT00814021 Kidney Cancer ... More >> Metastatic Cancer Less << Phase 2 Completed - France ... More >> Institut Claudius Regaud Toulouse, France, 31052 Less <<
NCT01147822 - Active, not recruiting - -
NCT01309633 Nasopharyngeal Carcinoma Phase 2 Unknown September 2018 Singapore ... More >> National University Hospital Recruiting Kent Ridge, Singapore, 119074 Contact: Boon Cher Goh, MBBS    (65) 6772 4140    Boon_Cher_Goh@nuhs.edu.sg    Contact: Christine Vergara    (65) 6772 4619    christine_vergara@nuhs.edu.sg    Sub-Investigator: Boon Cher Goh, MBBS Less <<
NCT02404584 - Recruiting September 2018 France ... More >> CHRU de Montpellier - Hôpital Saint-Eloi Recruiting Montpellier cedex 5, France, 34295 Principal Investigator: Délphine Topart, MD          CHRU de Nîmes - Hôpital Universitaire Carémeau Recruiting Nîmes Cedex 09, France, 30029 Principal Investigator: Nadine Houédé, MD, PhD          Sub-Investigator: Alexandre Evard, Pharmd, PhD          Sub-Investigator: Jean-Christophe Boyer, MD, PhD          Institut de Cancérologie du Gard (ICG) Recruiting Nîmes Cedex 9, France, 30029 Principal Investigator: Angélique Chapellie, MD Less <<
NCT00393796 Bladder Cancer Phase 2 Terminated(Low accrual) - United States, California ... More >> David Geffen School of Medicine at UCLA Los Angeles, California, United States, 90095 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 Columbia University Medical Center New York, New York, United States, 10032 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00372424 - Completed - -
NCT00578526 Urothelial Cancer ... More >> Bladder Cancer Adult Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Health Sciences Centre London, Ontario, Canada, T6A 4L6 Less <<
NCT00393796 - Terminated(Low accrual) - -
NCT00254540 Carcinoma, Renal Cell Phase 2 Completed - Japan ... More >> Pfizer Investigational Site Sapporo, Hokkaido, Japan Pfizer Investigational Site Tsukuba, Ibaragi, Japan Pfizer Investigational Site Osakasayama, Osaka, Japan Pfizer Investigational Site Hamamatsu, Shizuoka, Japan Pfizer Investigational Site Sunto-gun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Pfizer Investigational Site Akita, Japan Pfizer Investigational Site Fukuoka, Japan Pfizer Investigational Site Osaka, Japan Pfizer Investigational Site Tokushima, Japan Pfizer Investigational Site Yamagata, Japan Less <<
NCT00694096 Renal Cell Cancer Phase 1 Completed - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00291577 Breast Neoplasms Phase 1 Completed - Belgium ... More >> Pfizer Investigational Site Bruxelles, Belgium, 1000 Italy Pfizer Investigational Site Milano, Italy, 20133 Sweden Pfizer Investigational Site Stockholm, Sweden, 171 76 Less <<
NCT00694096 - Completed - -
NCT00849186 - Completed - -
NCT01934452 - Recruiting April 15, 2020 France ... More >> CHU de la Timone Recruiting Marseille, Cedex 5, France, 13335 CHRU HOTEL DIEU - Service Urologie Recruiting Angers Cedex, France, 49933 C.H.U Morvan Recruiting Brest, France, 29000 Clinique Victor Hugo Recruiting Le Mans, France, 72015 Institut Paoli-Calmettes Recruiting Marseille Cedex 09, France, 13273 Institut Paoli-Calmettes / Hôpital de jour Recruiting Marseille Cedex 9, France, 13273 Cedex 9 Hopital Timone Adultes Recruiting Marseille Cedex, France, 13385 CRLC Val d'Aurelle Recruiting Montpellier cedex 05, France, 34295 Hopital Europeen Georges Pompidou Recruiting Paris Cedex 15, France, 75908 Centre Hospitalier Lyon Sud Recruiting Pierre Bénite Cedex, France, 69495 Clinique Chirurgicale de l'Orangerie, Chiliotherapie Recruiting Strasbourg, France, 67010 Centre Alexis Vautrin Recruiting Vandoeuvre les Nancy, France, 54511 Institut Gustave Roussy Active, not recruiting Villejuif Cedex, France, 94805 Less <<
NCT00291577 - Completed - -
NCT02282059 - Recruiting December 12, 2022 China, Anhui ... More >> Oncology Department, The Second Affiliated Hospital of Anhui Medical University Active, not recruiting Hefei, Anhui, China, 230061 China, Beijing Cancer Institute and Hospital, Chinese Academy of Medical Science Not yet recruiting Beijing, Beijing, China, 100021 Department of Medical Oncology, Cancer Institute and Hospital, Chinese Academy of Medical Sciences Active, not recruiting Beijing, Beijing, China, 100021 China, Guangdong SUN Yat-Sen University Cancer Center Active, not recruiting Guangzhou, Guangdong, China, 510060 China, Heilongjiang The Affiliated Tumour Hospital of Harbin Medical University Recruiting Haerbin, Heilongjiang, China, 150081 China, Henan The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 China, Jiangsu Nanjing Bayi Hospital Active, not recruiting Nanjing, Jiangsu, China, 210002 Nanjing General Hospital of Nanjing Military Command/Hepatobiliary Surgery Department Active, not recruiting Nanjing, Jiangsu, China, 210002 Jiangsu Cancer Hospital Active, not recruiting Nanjing, Jiangsu, China, 210009 Jiangsu Province Hospital Active, not recruiting Nanjing, Jiangsu, China, 210029 China, Shannxi Digestive surgery Department, The First Affiliated Hospital, The Fourth Military Medical University Recruiting Xi'an, Shannxi, China, 710032 China, Sichuan West China Hospital of Sichuan University/Hepatobiliary Pancreatic Surgery Recruiting Chengdu, Sichuan, China, 610041 China, Tianjin Tianjin Cancer Hospital Active, not recruiting Tianjin, Tianjin, China, 300060 China, Zhejiang Zhejiang Cancer Hospital, Oncology department Active, not recruiting Hangzhou, Zhejiang, China, 310022 China The PLA of 307 Hospital Active, not recruiting Beijing, China, 100071 Fudan University Shanghai Cancer Center Active, not recruiting Shanghai, China, 200032 Tianjin Medical University General Hospital/General Surgery Active, not recruiting Tianjin, China, 300052 Less <<
NCT00712504 Advanced Solid Tumors ... More >> Non Small Cell Lung Cancer Less << Phase 1 Completed - United States, Alabama ... More >> Pfizer Investigational Site Birmingham, Alabama, United States, 35233-2115 Pfizer Investigational Site Birmingham, Alabama, United States, 35233 Pfizer Investigational Site Birmingham, Alabama, United States, 35294 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT01441661 - Completed - China, Beijing ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Beijing, Beijing, China, 100021 China, Hubei Tongji Hospital, Tongji Medical College of Hust Wuhan, Hubei, China, 430030 Less <<
NCT01121562 Pancreatic Neuroendocrine Tumo... More >>rs Less << Phase 2 Completed - Japan ... More >> Aichi Cancer Center Central Hospital Nagoya, Aichi, Japan National Cancer Center Hospital Chuo-ku, Tokyo, Japan Kyushu University Hospital Fukuoka, Japan Osaka Police Hospital Osaka, Japan Less <<
NCT00254540 - Completed - -
NCT00398112 - Completed - -
NCT01164202 Liver Cancer Phase 2 Phase 3 Completed - France ... More >> CHU Nord Amiens, France CHR Annecy, France Institut Sainte Catherine Avignon, France CHU J Minjoz Besancon, France Institut Bergonié Bordeaux, France CH Béziers, France CHU Côte de Nacre Caen, France CHU Clermont Ferrand, France Clinique des Cèdres Cornebarrieu, France CHU Bocage Dijon, France CH Guilherand Granges, France Hôpital Claude Huriez Lille, France, 59037 Hopital Dupuytren Limoges, France CHBS Lorient, France Hôpital Privé Jean Mermoz Lyon, France CH Ambroise Paré Marseille, France CH Conception Marseille, France CHU La Timone Marseille, France Hôpital Saint Joseph Marseille, France CHRU Saint Eloi Montpellier, France CHU -Hôpital de l'Archet II Nice, France CHR Orléans, France Hopital Tenon Paris, France, 75970 Groupe Hospitalier Paris St Joseph Paris, France Hôpital Européen Georges Pompidou Paris, France CHU Jean Bernard Poitiers, France CHU Robert Debré Reims, France CAC Rennes, France CHU Rouen, France CHU Tours, France Institut Gustave Roussy Villejuif, France Less <<
NCT00906360 Metastatic Squamous Neck Cance... More >>r With Occult Primary Squamous Cell Carcinoma Recurrent Metastatic Squamous Neck Cancer With Occult Primary Recurrent Salivary Gland Cancer Recurrent Squamous Cell Carcinoma of the Hypopharynx Recurrent Squamous Cell Carcinoma of the Larynx Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity Recurrent Squamous Cell Carcinoma of the Nasopharynx Recurrent Squamous Cell Carcinoma of the Oropharynx Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Recurrent Verrucous Carcinoma of the Larynx Recurrent Verrucous Carcinoma of the Oral Cavity Salivary Gland Squamous Cell Carcinoma Stage III Salivary Gland Cancer Stage III Squamous Cell Carcinoma of the Hypopharynx Stage III Squamous Cell Carcinoma of the Larynx Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity Stage III Squamous Cell Carcinoma of the Nasopharynx Stage III Squamous Cell Carcinoma of the Oropharynx Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage III Verrucous Carcinoma of the Larynx Stage III Verrucous Carcinoma of the Oral Cavity Stage IV Salivary Gland Cancer Stage IV Squamous Cell Carcinoma of the Hypopharynx Stage IV Squamous Cell Carcinoma of the Larynx Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity Stage IV Squamous Cell Carcinoma of the Nasopharynx Stage IV Squamous Cell Carcinoma of the Oropharynx Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Stage IV Verrucous Carcinoma of the Larynx Stage IV Verrucous Carcinoma of the Oral Cavity Tongue Cancer Untreated Metastatic Squamous Neck Cancer With Occult Primary Less << Phase 1 Terminated - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Evanston CCOP-NorthShore University HealthSystem Evanston, Illinois, United States, 60201 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Loyola University Medical Center Maywood, Illinois, United States, 60153 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 60702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc - State Boulevard Fort Wayne, Indiana, United States, 46845 United States, Maryland University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201-1595 United States, Michigan University of Michigan University Hospital Ann Arbor, Michigan, United States, 48109 United States, Missouri Saint John's Mercy Medical Center Saint Louis, Missouri, United States, 63141 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00398112 B-cell Chronic Lymphocytic Leu... More >>kemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Minnesota ... More >> North Central Cancer Treatment Group Rochester, Minnesota, United States, 55905 Less <<
NCT00511849 Neoplasms Phase 1 Completed - United States, Michigan ... More >> Pfizer Investigational Site Detroit, Michigan, United States, 48201 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Texas Pfizer Investigational Site Houston, Texas, United States, 77030 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT01121562 - Completed - -
NCT01215565 Hepatocellular Carcinoma ... More >> Fibrolamellar Hepatocellular Carcinoma Less << Phase 2 Terminated(lack of inclusion) - France ... More >> Hôpital Beaujon Clichy, Hauts de Seine, France, 92110 Less <<
NCT01402089 Non Small-cell Lung Cancer ... More >> Renal-cell Cancer Gastrointestinal Stroma Tumor Less << Phase 4 Completed - Switzerland ... More >> Cantonal Hospital St.Gallen St.Gallen, Switzerland, 9007 Less <<
NCT00903175 - Completed - -
NCT01210053 Non-small Cell Lung Cancer Phase 2 Unknown March 2012 China, Chongqing ... More >> Daping Hospital and the Research Institute of Surgery of the Third Military Medical University Recruiting Chongqing, Chongqing, China, 400042 Contact: yang zhenzhou, doctor       yangzhenzhou@sohu.com Less <<
NCT00903175 Renal Cell Carcinoma Phase 2 Completed - -
NCT00421512 Metastatic Renal Cell Carcinom... More >>a Kidney Cancer Less << Phase 1 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center 1275 York Avenue New York, New York, United States, 10021 Less <<
NCT01850147 Cancer Lung C... More >>ancer Less << Phase 2 Unknown December 2014 China ... More >> Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting Beijing, China, 100021 Less <<
NCT01673386 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - -
NCT01070706 Breast Cancer Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Center for breast cancer, National Cancer Center Goyang, Kyeonggido, Korea, Republic of, 410-769 Less <<
NCT01185366 Kidney Cancer Phase 2 Active, not recruiting August 2019 United States, Massachusetts ... More >> Dana-Farber Cancer Institute/Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute - University of Utah Salt Lake City, Utah, United States, 84112 Less <<
NCT00806663 Metastatic Colorectal Cancer ... More >> Liver Metastases Less << Phase 2 Completed - Germany ... More >> Innere Univ.-Klinik u. Poliklinik Tumorforschung Essen, Germany, D-45122 Klinik für Tumorbiologie Freiburg, Germany, D-79106 Medizinische Universitätsklinik der Albert-Ludwigs-Universität Freiburg Freiburg, Germany, D-79106 Marienhospital Herne, Germany, D-44625 Less <<
NCT03641326 Gliosarcoma C... More >>entral Nervous System Sarcoma Less << Phase 2 Not yet recruiting September 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Not yet recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01164228 Kidney Cancer Phase 2 Active, not recruiting May 31, 2023 -
NCT02761057 Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Unresectable Renal Cell Carcinoma Less << Phase 2 Suspended(Scheduled Interim Mo... More >>nitoring) Less << - -
NCT00617253 Cancer Renal ... More >>Cell Carcinoma Less << Phase 2 Completed - Germany ... More >> Novo Nordisk Investigational Site Frankfurt, Germany, 60488 Novo Nordisk Investigational Site Hamburg, Germany, 20246 Novo Nordisk Investigational Site Hannover, Germany, 30625 Netherlands Novo Nordisk Investigational Site Amsterdam, Netherlands, 1066 CX Novo Nordisk Investigational Site Nijmegen, Netherlands, 6525 GA Less <<
NCT01829841 Renal Cell Cancer ... More >> Metastatic Renal Cell Cancer Less << Phase 2 Completed - China ... More >> Cancer Institute and Hospital Chinese Academy of Medical Sciences Beijing, China, 100021 Less <<
NCT01907607 Advanced Gastrointestinal Stro... More >>mal Tumors Less << Phase 2 Active, not recruiting April 2019 France ... More >> Institut Bergonié Bordeaux, Gironde, France, 33076 Centre Georges-Francois Leclerc Dijon, France, 21079 Centre Oscar Lambret Lille, France, 59020 Centre Léon Bérard Lyon, France, 69373 Hôpital de la Timone - AP-HM Marseille, France, 13385 Centre René Gauducheau Nantes, France, 44805 Hôpital Saint-Antoine (AP-HP) Paris, France, 75571 CHU de REIMS - Hôpital Robert Debré Reims, France, 51092 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT00570635 Gastrointestinal Stromal Tumor... More >>s Gastrointestinal Neoplasms Less << Phase 2 Completed - United States, California ... More >> Los Angeles, California, United States, 90095 United States, Illinois Park Ridge, Illinois, United States, 60068 United States, Massachusetts Boston, Massachusetts, United States, 02115 Less <<
NCT00489944 Intraocular Melanoma Phase 2 Unknown - United States, California ... More >> San Diego Pacific Oncology and Hematology Associates, Incorporated - Encinitas Recruiting Encinitas, California, United States, 92024 Contact: Edward F. McClay, MD    760-452-3340    emcclay@pacificoncology.com Less <<
NCT00979329 - Completed - Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less <<
NCT00930345 Metastatic Renal Cell Carcinom... More >>a Less << Phase 4 Terminated - France ... More >> HEGP Paris, France, 75015 Less <<
NCT00471328 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - -
NCT00471328 - Completed - -
NCT00491738 Renal Cell Carcinoma Phase 2 Terminated(Based on the data c... More >>ollected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.) Less << - -
NCT01216371 Renal Cell Carcinoma ... More >> Pulmonary Metastases Less << Phase 2 Unknown October 2015 Germany ... More >> Universitätsmedizin Charité Berlin Not yet recruiting Berlin, Germany, 10117 Contact: Steffen Weikert, Priv. Doz. Dr. med.    030/84 45-40 84       Principal Investigator: Steffen Weikert, Priv. Doz. Dr. med.          Sub-Investigator: Kempkensteffen Carsten, Dr. med.          Sub-Investigator: Jonas Busch, Dr. med.          Sub-Investigator: Jan Gregor, Dr. med.          Sub-Investigator: Jens Neudecker, Dr. med.          Sub-Investigator: Jens C. Rückert, Dr. med.          Sub-Investigator: Gertrud Feldmann          Franziskus Krankenhaus Not yet recruiting Berlin, Germany, 10787 Contact: Jörg Neymeyer, Dr. med.    030/26 38-38 01       Principal Investigator: Jörg Neymeyer, Dr. med.          Sub-Investigator: Thomas Wülfing, Dr. med.          Helios Klinikum Emil von Behring Not yet recruiting Berlin, Germany, 14165 Contact: Kollmeier Jens, Dr. med.    030/81 02-14 47       Sub-Investigator: Jens Kollmeier, Dr. med.          Sub-Investigator: Bettina Schlolaut, Dr. med.          university hospital of Düsseldorf Recruiting Düsseldorf, Germany, 40255 Contact: Peter Albers, Prof. Dr. med.    0211/811-81 10       Principal Investigator: Peter Albers, Prof. Dr. med.          Sub-Investigator: Jasper Decoene          Sub-Investigator: Zenginli Hakan          Sub-Investigator: Claus F. Eisenberger, Prof. Dr. med.          Sub-Investigator: Wolfram T. Knoefel, Prof. Dr. med.          Sub-Investigator: Almut Diem          university hospital of Essen Recruiting Essen, Germany, 45122 Contact: Herbert Rübben, Prof. Dr. med.    0201/723-32 10       Principal Investigator: Herbert Rübben, Prof. Dr. med.          Sub-Investigator: Marcus Schenk, Dr. med.          Sub-Investigator: Farnk vom Dorp, Dr. med.          Sub-Investigator: Min Ju, Dr. med.          Sub-Investigator: Stephan Tschirdewahn          Sub-Investigator: Michaela Löbert          Ruhrlandklinik Department of Thoracic Surgery Not yet recruiting Essen, Germany, 45239 Contact: Christiane Zimmermann    0201/433-43 24       Sub-Investigator: Georgios Stamatis, Prof. Dr. med.          Sub-Investigator: Stefan Welter, Dr. med.          Sub-Investigator: Silvia Fechner, Dipl. med.          university hospital of Freiburg Recruiting Freiburg, Germany, 79106 Contact: Ulrich Wetterauer, Prof. Dr. med.    0761/270-2891       Principal Investigator: Ulrich Wetterauer, Prof. Dr. med.          Sub-Investigator: Christian Leiber, Dr. med.          Sub-Investigator: Christian Stremmel, Prof. Dr. med.          Sub-Investigator: Jutta Günter, Dr. med.          university Hospital of Heidelberg Recruiting Heidelberg, Germany, 69119 Contact: Markus Hohenfellner, Prof. Dr. med.    06221/56-63 21       Principal Investigator: Markus Hohenfellner, Prof. Dr. med.          Sub-Investigator: Pahernick Sascha, Priv. Doz. Dr. med.          Sub-Investigator: Gencay Hatiboglu, Dr. med.          Sub-Investigator: Johannes Huber, Dr. Dr. med.          Sub-Investigator: Joachim Pfannschmidt, Priv. Doz. Dr. med.          Sub-Investigator: Hendrik Dienemann, Prof. Dr. med.          urological hospital of Maria Hilf Krankenhaus Krefeld Recruiting Krefeld, Germany, 47805 Contact: Susanne Krege, Priv. Doz. Dr. med.    02151/334-52 74       Principal Investigator: Susanne Krege, Priv. Doz. Dr. med.          Sub-Investigator: Florian Hartmann, Dr. med.          Hospital of Großhadern Not yet recruiting München, Germany, 81377 Contact: Michael Staehler, Dr. med.    089/70 95-0       Principal Investigator: Michael Staehler, Dr. med.          Sub-Investigator: Cordula Nordhaus, Dr. med.          Sub-Investigator: Philipp Nuhn, Dr. med.          Sub-Investigator: Hauke Winter, Priv. Doz. Dr. med.          Sub-Investigator: Rudolf Hatz, Prof. Dr. med.          Sub-Investigator: Sylvia Dondl          Dr.-Horst-Schmidt-Kliniken GmbH Recruiting Wiesbaden, Germany, 65199 Contact: Norbert Frickhofen, Prof. Dr. med.    0611/43-30 09       Principal Investigator: Norbert Frickhofen, Prof. Dr. med.          Sub-Investigator: Bernd Jung, Dr. med.          Sub-Investigator: Heinz G. Fuhr, Dr. med.          Sub-Investigator: Joachim Schirren, Prof. Dr. med.          Sub-Investigator: Servet Bölükbas, Dr. med.          Sub-Investigator: Sabine Labenz          Sub-Investigator: Birgit Wilde          Sub-Investigator: Klaudia Fischbach Less <<
NCT00532064 - Terminated(Terminated per PI's... More >> request) Less << - United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00075218 Gastrointestinal Stromal Tumor Phase 3 Completed - -
NCT00457392 Carcinoma, Non-Small Cell Lung Phase 3 Completed - -
NCT00075218 - Completed - -
NCT00434356 Metastatic Breast Cancer Phase 2 Terminated(Based on data colle... More >>cted, the combination appeared to be poorly tolearated.) Less << - -
NCT00491738 - Terminated(Based on the data c... More >>ollected, the combination of bevacizumab and sunitinib appeared to be poorly tolerated.) Less << - -
NCT00626509 Kidney Cancer Phase 2 Unknown - Italy ... More >> Ospedale Sacro Cuore Recruiting Negrar, Italy, 37024 Contact: Contact Person    39-045-601-3912 Less <<
NCT00434356 - Terminated(Based on data colle... More >>cted, the combination appeared to be poorly tolearated.) Less << - -
NCT00457392 - Completed - -
NCT00709995 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Active, not recruiting December 2018 Austria ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Vienna, Austria, A1090 France For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Villejuif, France, 94805 Italy For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Rome, Italy, 00149 Poland For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Warsaw, Poland, 00909 Less <<
NCT03519542 - Active, not recruiting June 2018 Spain ... More >> Hospital Clínico Universitario de Santiago de Compostela Santiago de Compostela, A Coruña, Spain, 15706 Hospital Universitario central de Asturias Oviedo, Asturias, Spain, 33011 Hospital Marqués de Valdecilla Santander, Cantabria, Spain, 39008 Hospital Universitarios de Burgos Burgos, Spain, 09006 Hospital Universiario de León León, Spain, 24080 Hospital Gregorio Marañón Madrid, Spain, 28007 Hospital Universitario Ramón y Cajal Madrid, Spain, 28024 Hospital Clínico (Madrid) Madrid, Spain, 28040 Hospital 12 de Octubre Madrid, Spain, 28041 Hospital Universitario La Paz Madrid, Spain Hospital Universitario Carlos Haya Málaga, Spain, 29010 Hospital Clínico Lozano Blesa Zaragoza, Spain, 50009 Less <<
NCT01246843 - Completed - Netherlands ... More >> University Medical Centre Nijmegen Nijmegen, Gelderland, Netherlands, 6500 HB Less <<
NCT02428335 - Unknown June 2017 Canada, Alberta ... More >> Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Less <<
NCT00537056 Kidney Neoplasms ... More >> Carcinoma, Renal Cell Kidney (Renal Cell) Cancer Less << Not Applicable Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00732914 Renal Cell Carcinoma Phase 3 Completed - Germany ... More >> Urologische Klinik Mannheim, Baden-Wuerttemberg, Germany, 68167 Less <<
NCT01014065 - Completed - Canada, Alberta ... More >> University of Alberta/ Cross Cancer Institute Edmonton, Alberta, Canada Less <<
NCT00077987 Colorectal Neoplasms Phase 2 Completed - -
NCT01122888 Adult Giant Cell Glioblastoma ... More >> Adult Glioblastoma Adult Gliosarcoma Adult Solid Neoplasm Recurrent Adult Brain Neoplasm Less << Phase 1 Terminated - United States, Illinois ... More >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Less <<
NCT03013946 Renal Cell Carcinoma, Metastat... More >>ic Renal Cell Cancer, Recurrent Less << Phase 3 Recruiting May 2020 Germany ... More >> Medizinische Hochschule Hannover Not yet recruiting Hannover, Germany, 30625 Contact: Viktor Grünwald, Dr.    +49 511 532 ext 2301    gruenwald.viktor@mh-hannover.de    Zentrum für Onkologie und Urologie Rostock Recruiting Rostock, Germany, 18107 Contact: Andreas Hübner, Dr. Less <<
NCT00915993 Kidney Cancer Not Applicable Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT00553696 Stomach Neoplasms Phase 1 Completed - Japan ... More >> Aichi cancer center central hospital / Medical Oncology Nagoya, Aichi, Japan, 464-8681 Saku Central Hospital, GI Devision Saku, Nagano, Japan Shizuoka Cancer Center Suntougun, Shizuoka, Japan, 411-8777 Less <<
NCT02184416 - Recruiting July 20, 2019 -
NCT00553696 - Completed - -
NCT00226811 - Completed - -
NCT03075423 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting December 31, 2022 Germany ... More >> Medizinische Hochschule Hannover Recruiting Hannover, Niedersachsen, Germany, 30625 Charité Universitätsmedizin Berlin Recruiting Berlin, Germany University Hospital Erlangen Recruiting Erlangen, Germany, 91054 Contact: Stefan Krause, Prof.          Universitätsklinikum Essen Recruiting Essen, Germany Goethe University Frankfurt Recruiting Frankfurt am Main, Germany, D-60590 Contact: Lothar Prof. Dr. med. Bergmann, MD    +40 69 63015121    l.bergmann@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD          Uiversitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany Uniklinikum Recruiting Jena, Germany Universitätsklinkum Gießen und Marburg Recruiting Marburg, Germany Klinikum Rechts der Isar der TU München Recruiting München, Germany University of Muenster Recruiting Münster, Germany, 48149 Universitätsklinik Tübingen Recruiting Tübingen, Germany Medizinische Universitätsklinik Ulm Recruiting Ulm, Germany, 89070 Less <<
NCT00078000 Breast Neoplasms Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Greenbrae, California, United States, 94904 Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site San Francisco, California, United States, 94115 United States, Colorado Pfizer Investigational Site Aurora, Colorado, United States, 80010 United States, Illinois Pfizer Investigational Site Chicago, Illinois, United States, 60612-3824 United States, Indiana Pfizer Investigational Site Indianapolis, Indiana, United States, 46202 United States, Maryland Pfizer Investigational Site Baltimore, Maryland, United States, 21231 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 Pfizer Investigational Site Boston, Massachusetts, United States, 02215 Less <<
NCT00434226 Non-Small Cell Lung Cancer Phase 2 Terminated(Based on data colle... More >>cted, the combination appeared to be poorly tolearated.) Less << - -
NCT00434226 - Terminated(Based on data colle... More >>cted, the combination appeared to be poorly tolearated.) Less << - -
NCT00226811 Stomach Neoplasms Phase 2 Completed - China, Jiangsu ... More >> Pfizer Investigational Site Nanjing, Jiangsu, China, 210002 China Pfizer Investigational Site Beijing, China, 100036 Pfizer Investigational Site Beijing, China Pfizer Investigational Site Guangzhou, China, 510515 Hong Kong Pfizer Investigational Site Hong Kong, Hong Kong Pfizer Investigational Site Shatin, Hong Kong Italy Pfizer Investigational Site Ancona, Italy, 60020 Pfizer Investigational Site Genova, Italy, 16132 Japan Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Suntougun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Korea, Republic of Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Pfizer Investigational Site Seoul, Korea, Republic of, 120-752 Pfizer Investigational Site Seoul, Korea, Republic of, 135-710 Pfizer Investigational Site Seoul, Korea, Republic of, 138-736 Portugal Pfizer Investigational Site Porto, Portugal, 4200-072 Taiwan Pfizer Investigational Site Kwei-Shan, Taoyuan, Taiwan, 333 Pfizer Investigational Site Taipei, Taiwan, 100 Less <<
NCT00836745 - Completed - India ... More >> Pfizer Investigational Site New Delhi, Delhi, India, 110 085 Pfizer Investigational Site Bangalore, Karnataka, India, 560 027 Pfizer Investigational Site Mumbai, Maharashtra, India, 400014 Pfizer Investigational Site Chandigard, Punjab, India, 141402 Pfizer Investigational Site Kolkata, West Bengal, India, 700 106 Pfizer Investigational Site Delhi, India, 110 060 Pfizer Investigational Site Jaipur, India, 302006 Less <<
NCT00836745 - Completed - -
NCT00137449 - Completed - -
NCT00137449 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - United States, Massachusetts ... More >> Pfizer Investigational Site Boston, Massachusetts, United States, 02115 France Pfizer Investigational Site Lyon Cedex 08, France, 69373 Pfizer Investigational Site Villejuif, France, 94805 Italy Pfizer Investigational Site Milano, Italy, 20133 Less <<
NCT02315625 Neuroendocrine Tumors ... More >> Neuroendocrine Carcinoma Neuroendocrine Neoplasms Carcinoma, Neuroendocrine Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas Less << Phase 2 Recruiting December 31, 2025 United States, Illinois ... More >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Xavier Keutgen, MD    312-563-1557    xavier_keutgen@rush.edu    United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00718562 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Japan ... More >> Novartis Investigative Site Nagoya, Aichi, Japan, 464-8681 Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Novartis Investigative Site Fukuoka-city, Fukuoka, Japan, 812-8582 Novartis Investigative Site Sapporo-city, Hokkaido, Japan, 060-8648 Novartis Investigative Site Niigata-city, Niigata, Japan, 951-8520 Novartis Investigative Site Suita-city, Osaka, Japan, 565-0871 Novartis Investigative Site Sunto-gun, Shizuoka, Japan, 411-8777 Novartis Investigative Site Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT00537056 - Completed - -
NCT00435409 Breast Neoplasms Phase 3 Completed - -
NCT01396408 Advanced Rare Tumours Phase 2 Active, not recruiting December 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia BCCA - Cancer Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BCCA - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Sciences Centre Halifax, Nova Scotia, Canada, B3H 1V7 Izaak Walton Killam (IWK) Health Centre Halifax, Nova Scotia, Canada, B3K 6R8 Canada, Ontario Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Ottawa Hospital Research Institute Ottawa, Ontario, Canada, K1H 8L6 Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Univ. Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec CHUM - Hopital Notre-Dame Montreal, Quebec, Canada, H2L 4M1 McGill University - Dept. Oncology Montreal, Quebec, Canada, H2W 1S6 CHU Sainte-Justine Montreal, Quebec, Canada, H3T 1C5 Canada, Saskatchewan Allan Blair Cancer Centre Regina, Saskatchewan, Canada, S4T 7T1 Saskatoon Cancer Centre Saskatoon, Saskatchewan, Canada, S7N 4H4 Less <<
NCT03424876 - Recruiting August 8, 2018 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China, 100142 Contact: Jian Li, MD Less <<
NCT02811861 Renal Cell Carcinoma Phase 3 Recruiting February 2021 -
NCT00923117 - Terminated(The study was termi... More >>nated based on results of an interim analysis for futility.) Less << - -
NCT00435409 - Completed - -
NCT00923117 Glioblastoma Multiforme ... More >> Malignant Gliomas Anaplastic Gliomas Less << Phase 2 Terminated(The study was termi... More >>nated based on results of an interim analysis for futility.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01506336 Gastro Intestinal Stromal Tumo... More >>r Less << Phase 2 Completed - France ... More >> Institute Gustave Roussy (IGR) Villejuif, France, 94815 Less <<
NCT00417677 Renal Cell Carcinoma Phase 1 Phase 2 Terminated(Decision was made n... More >>ot to attempt a lower dose) Less << - United States, Maryland ... More >> Baltimore, Maryland, United States, 21231 United States, Massachusetts Boston, Massachusetts, United States, 02215 United States, New York New York, New York, United States, 10021 United States, Pennsylvania Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00790595 Prostate Cancer Phase 1 Completed - United States, California ... More >> University of California, Los Angeles, Jonsson Comprehensive Cancer Center Los Angeles, California, United States, 90095 Less <<
NCT00979966 Non-clear Cell Renal Cell Canc... More >>er Less << Phase 2 Completed - Germany ... More >> Charité - Campus Virchow Klinikum Berlin, Germany Charité - Mitte Berlin, Germany Vivantes Klinikum am Urban Berlin, Germany Evangelische Kliniken Bonn gGmbH - Johanniter-Krankenhaus Bonn, Germany Universitätsklinikum Düsseldorf Düsseldorf, Germany Universitätsklinikum Essen Essen, Germany Klinikum der J.W. Goethe Universität Frankfurt, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany Universitätskrankenhaus Jena Jena, Germany UK-SH Campus Lübeck Lübeck, Germany Klinikum Oldenburg gGmbH Oldenburg, Germany Klinikum Stuttgart, Katharinenhospital Stuttgart, Germany Facharzt für Innere Medizin, Viersen, Germany Kliniken Nordoberpfalz AG - Klinikum Weiden Weiden, Germany Less <<
NCT02570789 Clear-cell Metastatic Renal Ce... More >>ll Carcinoma Less << Phase 4 Active, not recruiting December 2018 Belgium ... More >> Cliniques universitaires Saint-Luc Brussel, Belgium, 1200 Less <<
NCT00936832 Colorectal Cancer ... More >> Metastatic Cancer Less << Phase 2 Withdrawn(because the sunitini... More >>b showed futility in anotehr trial) Less << - France ... More >> Hopital Ambroise Pare Boulogne Billancourt, France, 92100 Less <<
NCT03141177 Renal Cell Carcinoma Phase 3 Recruiting April 22, 2023 -
NCT00570908 Breast Cancer Phase 2 Terminated(Due to poor accrual... More >> this study is being closed to accrual) Less << - United States, Texas ... More >> Lester and Sue Smith Breast Center at Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00570908 - Terminated(Due to poor accrual... More >> this study is being closed to accrual) Less << - -
NCT03729245 Renal Cell Carcinoma ... More >> Metastatic Renal Cell Carcinoma Less << Phase 3 Not yet recruiting June 2024 United States, California ... More >> Investigator Site - Whittier Not yet recruiting Whittier, California, United States, 90603 United States, Texas Investigator Site - Houston Not yet recruiting Houston, Texas, United States, 77030 United States, Virginia Investigator Site - Leesburg Not yet recruiting Leesburg, Virginia, United States, 20176 Australia, South Australia Investigator Site - Kurralta Park Not yet recruiting Kurralta Park, South Australia, Australia, 5037 Less <<
NCT02401815 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Active, not recruiting March 2020 United States, Florida ... More >> Sylvester Comprehensive Cancer Center/ UMHC Miami, Florida, United States, 33136 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio OSU Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02230176 Pancreatic Neuroendocrine Carc... More >>inoma Less << Phase 2 Recruiting October 2023 France ... More >> Gustave Roussy Recruiting Villejuif, Val De Marne, France, 94805 Contact: Lisa LAMBERT    0142116643 ext +33    lisa.lambert@gustaveroussy.fr    Principal Investigator: Eric BAUDIN, MD, PhD Less <<
NCT00373256 Breast Neoplasms Phase 3 Completed - -
NCT00054886 Kidney Neoplasms Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Los Angeles, California, United States, 90095 Pfizer Investigational Site Mission Hills, California, United States, 91345 Pfizer Investigational Site Monterey Park, California, United States, 91754 Pfizer Investigational Site Northridge, California, United States, 91328 Pfizer Investigational Site San Francisco, California, United States, 94115 Pfizer Investigational Site San Francisco, California, United States, 94121 United States, Massachusetts Pfizer Investigational Site Boston, Massachusetts, United States, 02114 Pfizer Investigational Site Boston, Massachusetts, United States, 02115 United States, Michigan Pfizer Investigational Site Ann Arbor, Michigan, United States, 48109 United States, Nevada Pfizer Investigational Site Henderson, Nevada, United States, 89052 Pfizer Investigational Site Las Vegas, Nevada, United States, 89109 Pfizer Investigational Site Las Vegas, Nevada, United States, 89128 United States, New York Pfizer Investigational Site New York, New York, United States, 10021 United States, Pennsylvania Pfizer Investigational Site Philadelphia, Pennsylvania, United States, 19111 United States, Wisconsin Pfizer Investigational Site Madison, Wisconsin, United States, 53792 Less <<
NCT01381822 Advanced Renal Cell Carcinoma ... More >> Gastrointestinal Stromal Tumors Pancreatic Neuroendocrine Tumors Less << Phase 1 Unknown June 2014 United States, Indiana ... More >> IU Health Goshen Center for Cancer Care Goshen, Indiana, United States, 46526 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 Less <<
NCT01371201 Malignant Progressive Pheochro... More >>mocytoma and Paraganglioma (PPGL) Less << Phase 2 Recruiting June 2021 France ... More >> Institut de Cancérologie Gustave roussy Recruiting Villejuif, France, 94805 Contact: Eric Baudin, MD       eric.baudin@igr.fr    Principal Investigator: Eric Baudin, MD          Sub-Investigator: Martin Schlumberger, MD          Sub-Investigator: Sophie Leboulleux, MD          Sub-Investigator: Cécile Chougnet, MD          Germany Universitätsklinikum Würzburg Recruiting Würburg, Germany, 97080 Contact: Martin FASSNACHT, MD    0931-201-39021       Principal Investigator: Martin FASSNACHT, MD          Italy University of Padova Recruiting Padova, Italy, 35128 Contact: Giusepe OPOCHER, MD    0498215503 ext +39       Principal Investigator: Giusepe OPOCHER, MD          Netherlands Radboud University Nijmegen Medical Centre Recruiting Nijmegen, GA, Netherlands, 6525 Contact: Henry TIMMERS, MD    0243614599 ext +31       Principal Investigator: Henry TIMMERS, MD Less <<
NCT00094029 - - - -
NCT00555672 - Completed - -
NCT00616122 Breast Cancer Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00373256 - Completed - -
NCT01246778 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT00748358 Prostatic Neoplasms ... More >> Neoplasms, Hormone-Dependent Tumor Markers, Biological Survival Rate Disease-Free Survival Less << Phase 2 Completed - France ... More >> Service Oncologie Médicale, Hopital Europeen Georges Pompidou Paris, France, 75015 Less <<
NCT00555672 Stomach Neoplasms Phase 1 Completed - Spain ... More >> Pfizer Investigational Site L'hospitalet de Llobregat, Barcelona, Spain, 08907 Pfizer Investigational Site Barcelona, Spain, 08003 Pfizer Investigational Site Madrid, Spain, 28041 Less <<
NCT00616122 - Completed - -
NCT01664182 Stage III Renal Cell Cancer AJ... More >>CC v7 Stage IV Renal Cell Cancer AJCC v7 Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 USC / Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 City of Hope South Pasadena South Pasadena, California, United States, 91030 United States, Michigan Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro Minnesota Community Oncology Research Consortium Saint Louis Park, Minnesota, United States, 55416 United States, New Jersey Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Pennsylvania Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States, 15232 United States, Virginia VCU Massey Cancer Center at Hanover Medical Park Mechanicsville, Virginia, United States, 23116 Less <<
NCT00372853 Carcinoma, Renal Cell Phase 1 Completed - United States, Arizona ... More >> Research Site Scottsdale, Arizona, United States, 85258 United States, New Jersey Research Site New Brunswick, New Jersey, United States, 08903 United States, Ohio Research Site Cleveland, Ohio, United States, 44195 United States, South Carolina Research Site Greenville, South Carolina, United States, 29605 United States, Tennessee Research Site Memphis, Tennessee, United States, 38120 Less <<
NCT00113516 Non-small Cell Lung Cancer Phase 2 Completed - -
NCT00130897 - - - -
NCT00137423 Carcinoma, Renal Cell Metastas... More >>is Less << Phase 2 Completed - United States, California ... More >> Pfizer Investigational Site Stanford, California, United States, 94305 United States, Nevada Pfizer Investigational Site Las Vegas, Nevada, United States, 89135 France Pfizer Investigational Site Villejuif, France, 94805 Germany Pfizer Investigational Site Berlin, Germany, 10117 Pfizer Investigational Site Muenchen, Germany, 81664 Greece Pfizer Investigational Site Thessaloniki, Greece, 56429 Netherlands Pfizer Investigational Site Nijmegen, Gld, Netherlands, 6525 GA Sweden Pfizer Investigational Site Lund, Sweden, SE-221 85 Pfizer Investigational Site Stockholm, Sweden, 171 76 Switzerland Pfizer Investigational Site St. Gallen, Switzerland, CH-9007 Less <<
NCT00430261 Lung Cancer A... More >>denocarcinoma Less << Phase 2 Completed - United States, Washington ... More >> Swedish Cancer Institute Seattle, Washington, United States, 98104 Less <<
NCT01694277 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Recruiting December 2022 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33000 Less <<
NCT00083889 - Completed - -
NCT00137423 - Completed - -
NCT00243503 - Completed - -
NCT00113516 - Completed - -
NCT01459757 - Completed - -
NCT00631410 Colorectal Neoplasms Phase 1 Completed - Japan ... More >> Pfizer Investigational Site Kashiwa, Chiba, Japan Pfizer Investigational Site Suntougun, Shizuoka, Japan Pfizer Investigational Site Chuo-ku, Tokyo, Japan Less <<
NCT00083889 Carcinoma, Renal Cell Phase 3 Completed - -
NCT00631410 - Completed - -
NCT02187042 - Completed - France ... More >> CHU de la Timone Marseille, Cedex 5, France, 13335 CHU Strasbourg Strasbourg, Cedex, France, 67091 Centre Hospitalier d'Annecy Annecy Cedex, France, 74011 Centre Catalan Urologie Andrologie Cabestany, France, 66330 Centre hospitalier de Chambery Chambery, France, 73000 Hopital prive La Louviere Lille, France, 59042 Clinique Claude Bernard Chimiotherapie Ambulatoire Metz, France, 57000 CRLC Val d'Aurelle Montpellier cedex 05, France, 34295 Polyclinique Gentilly Nancy, France, 54000 Polyclinique de Gentilly Service Oncologie Médicale Nancy, France, 54100 CHI de Cornouailles - Oncologie hospitalisation Quimper Cedex, France, 29107 Hopital Jean BERNARD - Tours - 7eme etage Valenciennes, France, 59300 Centre Alexis Vautrin Vandoeuvre les Nancy, France, 54511 Less <<
NCT00371553 Relapsed or Cisplatin-Refracto... More >>ry Germ Cell Cancer Less << Phase 2 Completed - Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T4N 4N2 Canada, British Columbia BC Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Nova Scotia QEII Health Science Center Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Centre London, Ontario, Canada, N6A 4L6 Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Less <<
NCT00904657 Blood Pressure Phase 1 Completed - -
NCT00531544 Metastatic Renal Cell Carcinom... More >>a Less << Not Applicable Completed - Saudi Arabia ... More >> KFSH&RC Riyadh, Saudi Arabia, 1211 Less <<
NCT00676650 Prostatic Neoplasms Phase 3 Terminated(Study A6181120 was ... More >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) Less << - -
NCT02019576 Clear Cell Metastatic Renal Ce... More >>ll Carcinoma Less << Phase 2 Recruiting December 2019 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Gerald Lim, MD       Gerald.Lim@albertahealthservices.ca    Principal Investigator: Gerald Lim, MD          Sub-Investigator: Daniel Heng, MD          Cross Cancer Institute Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Samir Patel, MD       Samir.Patel2@albertahealthservices.ca    Principal Investigator: Samir Patel, MD          Sub-Investigator: Scott North, MD          Canada, British Columbia BC Cancer Agency Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Christian Kollmannsberger, MD       ckollmannsberger@bccancer.bc.ca    Principal Investigator: Christian Kollmannsberger, MD          Canada, Manitoba Manitoba CancerCare Institute Recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Contact: Arbind Dubey, MD       adubey@cancercare.mb.ca    Sub-Investigator: Piotr Czaykowski, MD          Principal Investigator: Arbind Dubey, MD          Canada, Nova Scotia QEII Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Contact: Lori Wood, MD       lori.wood@cdha.nshealth.ca    Principal Investigator: Lori Wood, MD          Sub-Investigator: Derek Wilke, MD          Canada, Ontario Juravinski Cancer Centre Recruiting Hamilton, Ontario, Canada, L8V 5C2 Contact: Anand Swaminath, MD       Anand.swaminath@jcc.hhsc.ca    Principal Investigator: Anand Swaminath, MD          Sub-Investigator: Sebastian Hotte, MD          London Health Sciences Centre Recruiting London, Ontario, Canada, N6A 4L6 Contact: Belal Ahmad, MD       Belal.Ahmad@lhsc.on.ca    Principal Investigator: Belal Ahmad, MD          Sub-Investigator: George Rodrigues, MD          Ottawa Hospital Cancer Centre Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Scott Morgan, MD       smorgan@Ottawahospital.on.ca    Principal Investigator: Scott Morgan, MD          Sub-Investigator: Christina Canil, MD          Odette Cancer Centre, Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Georg Bjarnason, MD, FRCPC    416-480-5847    georg.bjarnason@sunnybrook.ca    Contact: Nesan Bandali, RN    416-480-6100 ext 82139    nesan.bandali@sunnybrook.ca    Principal Investigator: Georg Bjarnason, MD, FRCPC          Principal Investigator: Patrick Cheung, MD          Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Srikala Sridhar, MD       srikala.sridhar@uhn.on.ca    Principal Investigator: Srikala Sridhar, MD          Sub-Investigator: Anthony Brade, MD          Canada, Quebec McGill University Health Centre Recruiting Montreal, Quebec, Canada, H3G 1A4 Contact: Fabio Cury, MD       fabio.cury@gmail.com    Principal Investigator: Fabio Cury, MD          Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Tamim Niazi, MD       tniazi@jgh.mcgill.ca    Principal Investigator: Tamim Niazi, MD Less <<
NCT00982657 Solid Tumor Phase 2 Terminated(Refer to statement ... More >>in Summary Section/Detailed Description) Less << - United States, Arizona ... More >> Premiere Oncology of Arizona Scottsdale, Arizona, United States, 85258 United States, California Premiere Oncology, A Medical Corporation Santa Monica, California, United States, 90404 United States, Mississippi Boston Baskin Cancer Foundation Southaven, Mississippi, United States, 38671 United States, Oregon Providence Portland Medical Center Portland, Oregon, United States, 97213 United States, Tennessee Boston Baskin Cancer Foundation Bartlett, Tennessee, United States, 38133 Boston Baskin Cancer Foundation Germantown, Tennessee, United States, 38138 Boston Baskin Cancer Foundation Memphis, Tennessee, United States, 38120 Less <<
NCT00673504 Pancreatic Cancer Phase 2 Completed - Germany ... More >> Städtisches Klinikum Braunschweig Braunschweig, Germany, 38114 Universitätsklinikum Essen Essen, Germany, 45122 Krankenhaus Frankfurt, Germany, 60488 Klinikum der J. W. Goethe Universität; Zentrum der Inneren Medizin Frankfurt, Germany, 60590 Internistisches Facharztzentrum Frankfurt, Germany, 60596 Martin-Luther-Universität Halle-Wittenberg; Medizinische Fakultät Halle (Saale), Germany, 06097 Facharztpraxis Heidelberg, Germany, 69115 Klinikum Lüdenscheid Luedenscheid, Germany, 58515 Klinikum Nürnberg Nord Nürnberg, Germany, 90419 Robert-Bosch-Krankenhaus Stuttgart, Germany, 70376 Switzerland Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Less <<
NCT00982657 - Terminated(Refer to statement ... More >>in Summary Section/Detailed Description) Less << - -
NCT01024920 Carcinoma, Renal Cell Phase 2 Active, not recruiting February 15, 2019 Hungary ... More >> University of Pecs Medical School, Dept. of Oncotherapy Pecs, Hungary, 7624 Poland Ziemia Lubelska Oncological Center, Lublin Lublin, Poland, 20-099 Onco.Cent. - Instit. of Maria Sklodowskiej-Curie Warszawa, Poland, 02-781 Romania Military Central Clinical Emergency Hospital Bucharest, Romania, 010825 Sf. Nectarie Oncology Center, Craiova Craiova, Romania, 200347 ONCOLAB SRL, Craiova Craiova, Romania, 200385 Ukraine Municipal Establishment Cherkasy Oncology Centre Cherkasy, Ukraine, 18009 Bukovynsk State Medical University Chernivtsi, Ukraine, 58013 City Clinical Hospital #4, Dnipropetrovsk State Medical Academy Dnipropetrovks, Ukraine, 49102 CI of LRC Lviv Onco.Reg.Treat.&Diag.Cent. Lviv, Ukraine, 79031 Uzhgorod National University, Oncology Centre Uzhgorod, Ukraine, 88000 United Kingdom Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ Beatson West of Scotland Cancer Centre Glasgow, United Kingdom, G12 0YN Surrey Cancer Research Institute Guildford, United Kingdom, GU2 7WG St James's University Hospital Leeds, United Kingdom, LS9 7TF Less <<
NCT00513695 Inflammatory Breast Cancer ... More >> Male Breast Cancer Stage II Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Less << Phase 2 Active, not recruiting - United States, Alaska ... More >> Anchorage Oncology Centre Anchorage, Alaska, United States, 99508 Katmai Oncology Group Anchorage, Alaska, United States, 99508 United States, Arizona Arizona Cancer Center Tucson, Arizona, United States, 85724-5024 United States, Idaho Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States, 83712 United States, Washington Skagit Valley Hospital Mount Vernon, Washington, United States, 98273 Olympic Medical Center Port Angeles, Washington, United States, 98362 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03091192 Carcinoma Car... More >>cinoma, Renal Cell Kidney Neoplasms Urologic Neoplasms Kidney Diseases Neoplasms by Site Enzyme Inhibitors Protein Kinase Inhibitors Less << Phase 3 Active, not recruiting June 24, 2020 -
NCT00243503 Breast Neoplasms Phase 2 Completed - -
NCT00375674 Kidney Neoplasms Phase 3 Completed - -
NCT00513695 - Active, not recruiting - -
NCT02450123 Refractory Solid Tumors Not Applicable Recruiting December 2018 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Joon Oh Park, M.D., Ph.D    82 2 3410 3459    oncopark@skku.edu    Contact: yoon Jeong Ahn    221487395 ext 82 Less <<
NCT00522249 Carcinoma, Renal Cell Phase 1 Phase 2 Terminated(PI decision) - United States, Texas ... More >> Baylor College of Medicine - Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00541008 Kidney Cancer Phase 2 Unknown - France ... More >> Centre Paul Papin Recruiting Angers, France, 49036 Contact: Sophie Abadie-Lacourtoisie, MD    33-2-4135-2734       Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact: Ulrich Stein, MD    33-3-8166-8240       Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Alain Ravaud, MD, PhD    33-5-5679-5808    alain.ravaud@chu-bordeaux.fr    C.H.U. de Brest Recruiting Brest, France, 29609 Contact: Jean-Pierre Malhaire, MD    33-2-9822-3395       Centre Regional Francois Baclesse Recruiting Caen, France, 14076 Contact: Emmanuel Sevin, MD    33-2-3145-5017    e.sevin@baclesse.fr    CHU de Grenoble - Hopital de la Tronche Recruiting Grenoble, France, 38043 Contact: Matthieu Laramas, MD    33-4-7676-5333       Centre Hospitalier Departemental Recruiting La Roche Sur Yon, France, 85025 Contact: Franck Priou, MD    33-2-5144-6173    frank.priou@chd-vendee.fr    Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-3-2029-5942    acaty@o-lambret.fr    Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie Negrier, MD    33-4-7878-2751    negrier@lyon.fnclcc.fr    Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Gwenaelle Gravis, MD    33-4-9122-3740    gravisg@marseille.fnclcc.fr    CHU de la Timone Recruiting Marseille, France, 13385 Contact: Marjorie Baciuchka-Palmaro    33-91-385-708       Hopital Notre-Dame de Bon Secours Recruiting Metz, France, 57038 Contact: Sabine Walter, MD    33-387-553-554    s.walter@chr-metz-thionville.rss.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-8555    stculine@valdorel.fnclcc.fr    CRLCC Nantes - Atlantique Recruiting Nantes-Saint Herblain, France, 44805 Contact: Frederic Rolland, MD    33-2-40-67-99-76    F-rolland@nantes.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Jean Marc Ferrero, MD    33-4-9203-1511    jean-marc.ferrerero@nice.fnclcc.fr    Hopital Europeen Georges Pompidou Recruiting Paris, France, 75015 Contact: Stephane Oudard, MD, PhD    33-1-5609-3434    stephane.oudard@hop.egp.ap-hop-paris.fr    Hopital Saint Michel Recruiting Paris, France, 75015 Contact: Gael Deplanque, MD, MSC, PhD    33-1-4412-3078       Institut Jean Godinot Recruiting Reims, France, 51056 Contact: Herve Cure, MD, PhD    33-3-2650-4382       Hopital Foch Recruiting Suresnes, France, 92151 Contact: Christine Theodore, MD    33-1-4625-2149       Institut Claudius Regaud Recruiting Toulouse, France, 31052 Contact: Christine Chevreau-Dalbianco, MD    33-5-6142-4118    chevreau.christine@claudiusregaud.fr    Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Claude Linassier, MD, PhD    33-2-4747-3827    linassier@med.univ-tours.fr    Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Bernard Escudier, MD    33-1-4211-5410    escudier@igr.fr Less <<
NCT00676650 - Terminated(Study A6181120 was ... More >>prematurely discontinued due to futility on 27 September 2010. No new or unexpected safety issues were identified.) Less << - -
NCT01176799 Breast Cancer Phase 2 Unknown December 2017 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Soo Chin Lee, MBBS, MRCP    65 6772 4629    Soo_Chin_Lee@nuhs.edu.sg    Principal Investigator: Soo Chin Lee, MBBS, MRCP          National University Hospital Recruiting Singapore, Singapore, 119228 Less <<
NCT00953459 Lung Cancer Phase 2 Terminated(poorly recruiting) - Netherlands ... More >> Vrije Universiteit Medisch Centrum Amsterdam, Netherlands, 1007 MB Less <<
NCT00555620 Stomach Neoplasms Phase 1 Completed - Korea, Republic of ... More >> Pfizer Investigational Site Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707 Pfizer Investigational Site Goyang, Gyeonggi, Korea, Republic of, 410-769 Pfizer Investigational Site Seoul, Korea, Republic of, 110-744 Less <<
NCT00393939 Breast Neoplasms Phase 3 Completed - -
NCT00748163 Lung Cancer Phase 2 Withdrawn(Study has been aband... More >>oned for lack of available funding.) Less << August 2008 -
NCT00393939 - Completed - -
NCT00599924 Colorectal Neoplasms ... More >> Neoplasms Less << Phase 1 Completed - United States, Colorado ... More >> Pfizer Investigational Site Aurora, Colorado, United States, 80045 United States, Tennessee Pfizer Investigational Site Nashville, Tennessee, United States, 37232 United States, Texas Pfizer Investigational Site Dallas, Texas, United States, 75246 Less <<
NCT00792025 Bladder Cancer ... More >> Transitional Cell Cancer of the Renal Pelvis and Ureter Less << Phase 2 Completed - France ... More >> Centre Rene Huguenin Saint Cloud, France, 92211 Hopital Foch Suresnes, France, 92151 Less <<
NCT01258348 Metastatic Renal Cell Cancer Phase 1 Completed - United States, Indiana ... More >> For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Indianapolis, Indiana, United States, 46219 United States, South Carolina For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Greenville, South Carolina, United States, 29605 United States, Texas For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. The Woodlands, Texas, United States, 77380 United States, Virginia For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Norfolk, Virginia, United States, 23502 Canada, Quebec For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Montreal, Quebec, Canada, H3T 1E2 Less <<
NCT00555620 - Completed - -
NCT00375674 - Completed - -
NCT01258348 - Completed - -
NCT01984242 Renal Cell Carcinoma Phase 2 Active, not recruiting August 31, 2019 -
NCT00589784 CNS Cancer Me... More >>ningioma Intracranial Hemangiopericytoma Hemangioblastoma Neurofibromatosis Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States, 11725 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Pennsylvania University of Pittsburgh Medical Center Pittsburg, Pennsylvania, United States United States, Virginia University of Virginia Health Science Center Charlottesville, Virginia, United States, 22908 Less <<
NCT00411151 Gastric Adenocarcinoma ... More >> Barrett Esophagus Less << Phase 2 Completed - Germany ... More >> Universität Heidelberg, Nationales Zentrum für Tumorerkrankungen Heidelberg, Baden-Würtemberg, Germany, 69120 Universitätsklinikum Tübingen Tübingen, Baden-Würtemberg, Germany, 72076 TU München, Klinikum rechts der Isar, II. Med. Klinik und Poliklinik München, Bayern, Germany, 81675 Klinikum der Universität Würzburg Würzburg, Bayern, Germany, 97070 Universitätsklinikum der GHS Essen, Innere Klinik und Poliklinik, Tumorforschung Essen, Nordrhein-Westfalen, Germany, 45122 Universitätsklinik zu Köln, Klinik I für Innere Medizin Köln, Nordrhein-Westfalen, Germany, 50937 Klinikum der Johannes Gutenberg-Universität Mainz Mainz, Rheinland-Pfalz, Germany, 55131 Universitätsklinikum des Saarlandes Homburg/Saar, Saarland, Germany, 66421 Otto-von-Guericke-Universität Magdeburg Magdeburg, Sachsen-Anhalt, Germany, 39120 Universitätsklinikum Carl Gustav Carus, Med. Klinik I Dresden, Sachsen, Germany, 01307 Charité, Campus Benjamin Franklin Berlin, Germany, 12200 KH Nordwest, Abteilung für Hämatologie und Onkologie Frankfurt, Germany, 60488 Less <<
NCT01984242 - Active, not recruiting - -
NCT00428597 Carcinoma, Islet Cell ... More >> Carcinoma, Pancreas Less << Phase 3 Terminated(Refer to Detailed D... More >>escription.) Less << - -
NCT00599924 - Completed - -
NCT01472081 Renal Cell Carcinoma ... More >> Clear-cell Metastatic Renal Cell Carcinoma Less << Phase 1 Active, not recruiting June 2018 United States, California ... More >> City Of Hope Duarte, California, United States, 91010 United States, Maryland Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Hampshire Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Tennessee Oncology, Pllc Nashville, Tennessee, United States, 37203 United States, Texas The University Of Texas Md Anderson Cancer Center Houston, Texas, United States, 77030 Canada, Alberta Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia Bc Cancer Agency - Vancouver Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Princess Margaret Hospital-Uhn Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00411151 - Completed - -
NCT00589784 - Completed - -
NCT00428597 - Terminated(Refer to Detailed D... More >>escription.) Less << - -
NCT01446224 - Completed - -
NCT01039519 Gastrointestinal Stromal Tumor Phase 2 Completed - United States, California ... More >> UCLA Medical Center Los Angeles, California, United States, 90095 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health and Science University-Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111-2497 Less <<
NCT01468688 3rd Line GIST Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Institute SC (2) Boston, Massachusetts, United States, 02215 United States, Washington Seattle Cancer Care Alliance Onc Seattle, Washington, United States, 98105 Belgium Novartis Investigative Site Leuven, Belgium, 3000 Canada, British Columbia Novartis Investigative Site Vancouver, British Columbia, Canada, V5Z 4E6 France Novartis Investigative Site Lyon Cedex, France, 69373 Novartis Investigative Site Villejuif Cedex, France, 94805 Japan Novartis Investigative Site Kashiwa, Chiba, Japan, 277-8577 Netherlands Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site London, United Kingdom, SW3 6JJ Novartis Investigative Site Manchester, United Kingdom, M20 9BX Less <<
NCT01735968 3rd Line GIST Phase 1 Completed - United States, Oregon ... More >> Oregon Health and Science University Dept. of OHSU (3) Portland, Oregon, United States, 97239 Belgium Novartis Investigative Site Leuven, Belgium, 3000 France Novartis Investigative Site Bordeaux, France, 33076 Germany Novartis Investigative Site Berlin, Germany, 13125 Novartis Investigative Site Essen, Germany, 45122 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Candiolo, TO, Italy, 10060 Netherlands Novartis Investigative Site Groningen, Netherlands, 9713 GZ Novartis Investigative Site Leiden, Netherlands, 2300 RC Spain Novartis Investigative Site Barcelona, Catalunya, Spain, 08035 United Kingdom Novartis Investigative Site Leeds, United Kingdom, LS9 7TF Less <<
NCT00618319 GIST Phase 2 Completed - United States, California ... More >> Reseach Facility Encinitas, California, United States Research Site Santa Monica, California, United States, 90404 United States, Texas Reseach Facility San Antonio, Texas, United States Less <<
NCT00511511 - Completed - Netherlands ... More >> Erasmus MC Rotterdam, Netherlands, 3015 CE Less <<
NCT01689376 - - - -
NCT01646593 - - - -
NCT02268435 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Withdrawn(Dovitinib Production... More >> stopped) Less << November 2016 -
NCT02013089 Gastrointestinal Cancers Not Applicable Unknown December 2017 China, Guangdong ... More >> Gastrointestinal Hospital, Sun Yat-sen University Recruiting Guangzhou, Guangdong, China, 510655 Contact: Yanghong Deng, PhD    008613925106525    13925106525@163.com    Principal Investigator: Yanhong Deng, PhD Less <<
NCT02560012 Carcinoma, Renal Cell Phase 2 Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - United States, Texas ... More >> UTHealth Memorial Hermann Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01039519 - Completed - -
NCT01860118 - Completed - United States, Alabama ... More >> University of Alabama at Birmingham Sparks Center Birmingham, Alabama, United States, 35294 Less <<
NCT02560012 - Terminated(Loss of laboratory ... More >>performing molecular analysis) Less << - -
NCT00410124 Metastatic Renal Cell Carcinom... More >>a Less << Phase 3 Completed - -
NCT01219023 Hand Foot Syndrome ... More >> Palmar Plantar Erythrodysesthesia Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02779283 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting June 1, 2019 United States, Oregon ... More >> OHSU Knight Cancer Institute Recruiting Portland, Oregon, United States, 97239 Contact: Stephen E. Spurgeon    503-494-8950    spurgeos@ohsu.edu    Principal Investigator: Stephen E. Spurgeon Less <<
NCT01582672 Advanced Renal Cell Carcinoma ... More >> Renal Cell Carcinoma Metastatic Renal Cell Carcinoma Less << Phase 3 Terminated(Lack of efficacy) - -
NCT01441388 Carcinoma, Renal Cell ... More >> Glioblastoma Carcinoma, Hepatocellular Less << Phase 1 Withdrawn(Business/Operational... More >> issues) Less << November 2013 -
NCT01731158 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Unknown May 2016 Germany ... More >> Charité Berlin Berlin, Germany University Hospital Bonn Bonn, Germany University Hospital Dresden Dresden, Germany University Hospital Düsseldorf Düsseldorf, Germany Waldkrankenhaus St. Marien Erlangen, Germany University Hospital Essen Essen, Germany University Hospital Frankfurt Frankfurt, Germany University Hospital Freiburg Freiburg, Germany University Hospital Göttingen Göttingen, Germany Oncological Practice Hannover Hannover, Germany University Hospital Hannover Hannover, Germany University Hospital Magdeburg Magdeburg, Germany University Hospital Tübingen Tübingen, Germany Less <<
NCT01306045 Carcinoma, Non-Small-Cell Lung... More >> Carcinoma, Small Cell Lung Carcinoma, Thymic Less << Phase 2 Recruiting December 30, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00891475 Carcinoma, Renal Cell Phase 1 Phase 2 Completed - Russian Federation ... More >> Ilya Tsimafeyeu Moscow, Russian Federation, 109147 Less <<
NCT02187302 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - -
NCT01271712 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Active, not recruiting May 31, 2019 -
NCT00410124 - Completed - -
NCT02068170 - Completed - Belgium ... More >> UZ Leuven Leuven, Belgium, 3000 Less <<
NCT01271712 - Active, not recruiting - -
NCT02239952 Cancer High-g... More >>rade Glioma Less << Not Applicable Recruiting January 2019 Netherlands ... More >> VU University Medical Center Recruiting Amsterdam, Noord-Holland, Netherlands, 1081 HV Contact: H.M.W Verheul, MD, PhD    +31 (0)20 4444321    h.verheul@vumc.nl Less <<
NCT02216578 Metastatic Gastrointestinal St... More >>romal Tumor Less << Phase 2 Recruiting August 2019 Belgium ... More >> U.Z. Leuven - Campus Gasthuisberg (147) Recruiting Leuven, Belgium Contact: Patrick Schöffski          Czechia University Hospital Motol (1905) Recruiting Prague, Czechia Contact: Katerina Kopeckova-Kubackova          France Institut Bergonie (228) Recruiting Bordeaux, France Contact: Antoine Italiano          Centre Leon Berard (227) Recruiting Lyon, France Contact: Jean-Yves Blay          Gustave Roussy (225) Recruiting Villejuif, France Contact: Olivier Mir          Germany UniversitaetsMedizin Mannheim (527) Recruiting Mannheim, Germany Contact: Bernd Kasper          Hungary Military Hospital - State Health Centre (3769) Recruiting Budapest, Hungary Contact: Zsuzanna papai          United Kingdom Clatterbridge Centre for Oncology NHS Trust - Clatterbridge Cancer Centre NHS Foundation Trust (659) Recruiting Bebington, United Kingdom Contact: Ali Nasim          Royal Marsden Hospital - Chelsea, London (613) Recruiting Chelsea, United Kingdom Contact: Charlotte Benson          University College London Hospitals NHS Foundation Trust - University College Hospital (622) Recruiting London, United Kingdom Contact: Palma Dileo          The Christie NHS Foundation Trust (610) Not yet recruiting Manchester, United Kingdom Contact: Michael Leahy Less <<
NCT00782834 - Terminated(Stopped early for f... More >>utility, unable to meet accrual goals) Less << - -
NCT02889328 Gastrointestinal Stromal Tumor... More >>s (GISTs) Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00914043 - Withdrawn(Withdrawn as NCI res... More >>cinded approval for parent study NSABP-B-45) Less << - -
NCT01190241 Advanced Solid Tumors ... More >> Inoperable Metastasis Less << Not Applicable Unknown - Netherlands ... More >> Medical Center Alkmaar Alkmaar, Netherlands, 1815 JD VU University Medical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT01323400 GIST Phase 2 Completed - France ... More >> Institut Bergonié Bordeaux, France Centre Georges François Leclerc Dijon, France Centre Oscar Lambret Lille, France Centre Léon Bérard Lyon, France, F-69008 Hôpital de la Timone Marseille, France Institut Paoli Calmette Marseille, France Centre Alexis Vautrin Nancy, France Institut de Cancérologie de l'Ouest Nantes, France Hôpital St Antoine Paris, France Hôpital Tenon Paris, France CHU de Reims Reims, France Institut Cancerologie Neuwirth St Priest en Jarez, France Institut Gustave Roussy Villejuif, France Less <<
NCT01502228 Renal Cell Carcinoma Not Applicable Terminated(No further funding) - United States, Indiana ... More >> Indiana University Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00782834 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Terminated(Stopped early for f... More >>utility, unable to meet accrual goals) Less << - United States, Pennsylvania ... More >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT01502228 - Terminated(No further funding) - -
NCT00731211 Renal Cell Carcinoma Phase 2 Completed - United States, California ... More >> San Francisco Oncology Associates San Francisco, California, United States, 94115 United States, Florida Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Baptist Hospital East Louisville, Kentucky, United States, 40207 United States, Maine Central Maine Medical Center Lewiston, Maine, United States, 04240 United States, Michigan Grand Rapids Clinical Oncology Program Grand Rapids, Michigan, United States, 49503 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT02848768 - Completed - France ... More >> CHU de Rennes Rennes, France, 35033 Less <<
NCT01068769 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting December 2018 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 Less <<
NCT00731211 - Completed - -
NCT02264665 - Recruiting June 5, 2019 -
NCT01440959 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul,, Korea, Republic of, 138-736 Less <<
NCT01440959 - Completed - -
NCT01449825 - Completed - -
NCT03062410 Renal Carcinoma Metastatic ... More >> Kidney Neoplasms Renal Cancer Less << Not Applicable Recruiting February 4, 2020 France ... More >> CHU de Besançon Active, not recruiting Besançon, France, 25030 Hôpital privé Sainte Marie Recruiting Chalon-sur-Saône, France, 71100 Contact: Erika Viel, MD    0033385488989       Centre de lutte contre le cancer Georges François Leclerc Recruiting Dijon, France, 21000 Contact: Sylvain Ladoire, MD    0033380737506    sladoire@cgfl.fr    Hôpital Nord Franche-Comté Recruiting Montbéliard, France, 25200 Contact: Guillaume Mouillet, MD       mouillet.guillaume@gmail.com    Centre de lutte contre le cancer Jean Godinot Recruiting Reims, France, 51100 Contact: Jean-Christophe Eymard, MD          Groupe hospitaliser St-Vincent Recruiting Strasbourg, France, 67000 Contact: Louis-Marie Dourthe, MD       lm.dourthe@solcrr.org    Hôpitaux Universitaires de Strasbourg Recruiting Strasbourg, France, 67000 Contact: Philippe Barthelemy, MD       philippe.barthelemy@chru-strasbourg.fr    Centre de lutte contre le cancer Alexis Vautrin - Institut de Cancérologie de Lorraine Recruiting Vandœuvre-lès-Nancy, France, 54519 Contact: Lionnel Geoffrois, MD       l.geoffrois@nancy.unicancer.fr Less <<
NCT01482949 Renal Cell Carcinoma Phase 2 Terminated(Lack of efficacy) - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01566747 Renal Cell Carcinoma Phase 2 Active, not recruiting September 2018 Ireland ... More >> Beaumont Hospital Dublin, Leinster, Ireland Mater Misericordiae University Hospital Dublin, Leinster, Ireland Mater Private Hospital Dublin, Leinster, Ireland Cork University Hospital Cork, Ireland The Adelaide & Meath Hospital Dublin incorporating the National Children's Hospital Dublin, Ireland Galway University Hospital Galway, Ireland Mid-Western Regional Hospital Limerick, Ireland Waterford Regional Hospital Waterford, Ireland Sweden Karolinska University Hospital Stockholm, Sweden Less <<
NCT01068769 - Active, not recruiting - -
NCT02607332 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT03609424 Gastrointestinal Stromal Tumor... More >>s Less << Phase 1 Phase 2 Not yet recruiting August 30, 2020 -
NCT02380625 Ebola Virus Disease Phase 1 Phase 2 Unknown March 2016 -
NCT01620216 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 2 Recruiting March 30, 2019 United States, Maryland ... More >> National Heart Lung and Blood Institute Not yet recruiting Bethesda, Maryland, United States, 20824 Contact: Christopher S. Hourigan    301-803-8029    hourigan@nih.gov    Principal Investigator: Christopher S. Hourigan          United States, Oregon OHSU Knight Cancer Institute Not yet recruiting Portland, Oregon, United States, 97239 Contact: Marc Loriaux    503-494-9383    loriauxm@ohsu.edu    Principal Investigator: Marc Loriaux          United States, Texas UT Southwestern/Simmons Cancer Center-Dallas Recruiting Dallas, Texas, United States, 75390 Contact: Robert H. Collins    214-648-4155    robert.collins@utsouthwestern.edu    Principal Investigator: Robert H. Collins          United States, Utah Huntsman Cancer Institute/University of Utah Not yet recruiting Salt Lake City, Utah, United States, 84112 Contact: Tibor J. Kovacsovics    801-585-3229    tibor.kovacsovics@hci.utah.edu    Principal Investigator: Tibor J. Kovacsovics Less <<
NCT00976612 - Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT01058044 Cancer Not Applicable Completed - France ... More >> Centre Jean Perrin Clermont-Ferrand, France, 63011 Less <<
NCT00495872 Solid Tumors Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01151852 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Songpa-gu, Korea, Republic of, 138-736 Less <<
NCT02960906 Clear Cell Metastatic Renal Ce... More >>ll Carcinoma Less << Phase 2 Recruiting May 2020 France ... More >> Hôpital Saint André, CHU de Bordeaux Recruiting Bordeaux, France, 33075 Contact: Marine GROSS-GOUPIL, MD       marine.gross-goupil@chu-bordeaux.fr    Centre Francois Baclesse Recruiting Caen, France, 14000 Contact: Florence JOLY, MD,PHD       f.joly@baclesse.unicancer.fr    CHU Henri-Mondor Recruiting Creteil, France, 94000 Contact: Christophe TOURNIGAND, MD, PHD       christophe.tournigand@aphp.fr    CHD Vendée Not yet recruiting La Roche-sur-Yon, France, 85925 Contact: Franck PRIOU, MD       frank.priou@chd-vendee.fr    Centre OSCAR LAMBRET LILLE Recruiting Lille, France, 59000 Contact: Yaovi Messan AMELA, MD       e-amela@o-lambret.fr    Hôpital Européen Marseille Not yet recruiting Marseille, France, 13003 Contact: Philippe DALIVOUST       philippe.dalivoust@gmail.com    Institut Paoli Calmettes (IPC) Recruiting Marseille, France, 13009 Contact: Gwenaëlle GRAVIS, MD       gravisg@ipc.unicancer.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06100 Contact: Delphine BORCHIELLINI, MD       Delphine.BORCHIELLINI@nice.unicancer.fr    Institut de Cancérologie du Gard - CHU Caremeau Recruiting Nîmes, France, 30029 Contact: Nadine HOUEDE, MD,PHD       HOUEDE nadine    Hôpital Pitié-Salpêtrière Withdrawn Paris, France, 75013 Institut Mutualiste Montsouris Recruiting Paris, France, 75014 Contact: Mostefa BENNAMOUN, MD       Mostefa.Bennamoun@imm.fr    Hôpital Européen Georges Pompidou Recruiting Paris, France, 75015 Contact: Yann-Alexandre VANO, MD       yann.vano@aphp.fr    Hôpital de la Croix Saint-Simon Not yet recruiting Paris, France, 75020 Contact: Jacques MEDIONI       JMedioni@hopital-dcss.org    Hôpital Cochin Recruiting Paris, France, 75679 Contact: Olivier HUILLARD, MD       olivier.huillard@aphp.fr    Centre Hospitalier Lyon Sud - Institut de Cancérologie des Hospices Civils de Lyon (IC-HCL) Not yet recruiting Pierre Bénite, France, 69310 Contact: Denis MAILLET, MD       denis.maillet@chu-lyon.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Brigitte LAGUERRE, MD       b.laguerre@rennes.unicancer.fr    Centre René Gauducheau ICO institut de Cancerologie de l'Ouest Not yet recruiting Saint-Herblain, France, 44805 Contact: Frédéric ROLLAND, MD       Frederic.Rolland@ico.unicancer.fr    Hôpitaux universitaires de Strasbourg Recruiting Strasbourg, France, 67000 Contact: Philippe BARTHELEMY, MD       philippe.barthelemy@chru-strasbourg.fr    Hopital Foch Not yet recruiting Suresnes, France, 92151 Contact: Philippe BEUZEBOC       beuzeboc.philippe@gmail.com    Institut Claudius Regaud Recruiting Toulouse, France, 31059 Contact: Christine CHEVREAU, MD       Chevreau.Christine@iuct-oncopole.fr    CHU Bretonneau Recruiting Tours, France, 37000 Contact: Claude LINASSIER, MD       claude.linassier@univ-tours.fr    Institut Gustave Roussy Not yet recruiting Villejuif, France, 94805 Contact: Laurence ALBIGES, MD       Laurence.ALBIGES@gustaveroussy.fr Less <<
NCT01389583 Gastrointestinal Stromal Tumor Phase 2 Recruiting October 2019 Taiwan ... More >> National Health Research of Institutes, Taiwan Cooperative Oncology Group Recruiting Tainan, Taiwan Principal Investigator: Kun-Huei Yeh, PhD          Principal Investigator: Chueh-Chuan Yen, PhD          Principal Investigator: Ken-Hong Lim, MD          Principal Investigator: Jen-Shi Chen          Principal Investigator: Cheng-Chung Wu, MS          Principal Investigator: Chang-Fang Chiu, PhD          Principal Investigator: Kuan-Der Lee, PhD          Principal Investigator: Kun-Ming Rau, MPH          Sub-Investigator: Ann-Lii Cheng, PhD          Sub-Investigator: Yu-Lin Lin, MD          Sub-Investigator: Ta-Chung Chao, MD          Sub-Investigator: Wen-Liang Fang, MD          Sub-Investigator: Ruey-Kuen Hsieh, MD          Sub-Investigator: Chun-Nan Yeh, MD          Sub-Investigator: Youngsen Yang, MD          Sub-Investigator: Tseng-Hsi Lin, PhD          Sub-Investigator: Mei-Due Yang, PhD          Sub-Investigator: Li-Yuan Bai, MD          Sub-Investigator: Wu-Chou Su, MD          Sub-Investigator: Yan-Shen Shan, PhD          Sub-Investigator: Nai-Jung Chiang, MD          Sub-Investigator: Yen-Yang Chen, MD Less <<
NCT01977586 Metastatic Renal Cell Carcinom... More >>a Less << Not Applicable Withdrawn(Difficulty in recrui... More >>ting suitable patients at centre) Less << - United Kingdom ... More >> Imperial College Healthcare NHS Trust London, United Kingdom Less <<
NCT00749320 Renal Cell Carcinoma Not Applicable Active, not recruiting February 2019 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT03379012 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Recruiting July 30, 2019 Russian Federation ... More >> A.I. Kryzhanovsky Krasnoyarsk Cancer Center Recruiting Krasnoyarsk, Russian Federation Contact: Ruslan Zukov       kidneycancer@yandex.ru    Kidney Cancer Research Bureau Recruiting Moscow, Russian Federation Contact: Ilya Tsimafeyeu       kidneycancer@yandex.ru    RUDN University Recruiting Moscow, Russian Federation Contact: Yuliya Tishova       kidneycancer@yandex.ru    City Clinical Oncology Center Recruiting Saint Petersburg, Russian Federation Contact: Pavel Borisov       kidneycancer@yandex.ru Less <<
NCT03571438 Kidney Cancer Not Applicable Recruiting September 30, 2024 France ... More >> Grenoble Alps Hospital Recruiting Grenoble, France, 38043 Contact: Jean-Luc Descotes, PU-PH Less <<
NCT03170180 Stomach Neoplasms Phase 2 Recruiting October 31, 2020 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Sung Ju Park    234106820       Principal Investigator: Jeeyun Lee, M.D., Ph.D. Less <<
NCT02086695 - Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Canada, Manitoba St. Boniface General Hospital Winnipeg, Manitoba, Canada, R2H 2A6 Less <<
NCT01151852 - Completed - -
NCT01582009 Clear Cell Renal Cell Carcinom... More >>a Recurrent Renal Cell Cancer Stage III Renal Cell Cancer Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Terminated(pts off study, PI l... More >>eft institute) Less << - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00876382 - Completed - United States, Arkansas ... More >> Northeast Arkansas Clinic Jonesboro, Arkansas, United States, 72401 United States, Florida Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Georgia Medical Oncology Associates of Augusta Augusta, Georgia, United States, 30901 United States, Kentucky Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States, 40207 United States, Mississippi Jackson Oncology Associates Jackson, Mississippi, United States, 39202 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT01582204 Renal Cancer Not Applicable Active, not recruiting April 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00619268 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - France ... More >> Centre Paul Papin Angers, France Centre Hospitalier Universitaire de Besançon Besançon, France Centre Hospitalier Universitaire de Bordeaux - Hôpital St André Bordeaux, France Institut Bergonié Bordeaux, France Centre François Baclesse Caen, France Centre Jean Perrin Clermont Ferrand, France Centre Georges François Leclerc Dijon, France Centre Hospitalier de Versailles Le Chesnay, France Centre Hospitalier Universitaire de Lille - Hôpital Claude Huriez Lille, France Centre Oscar Lambret Lille, France Centre Hospitalier Universitaire DUPUTRYEN Limoges, France Centre Léon Bérard Lyon, France, 69373 Centre Hospitalier Universiariare Lyon, Hôpital Lyon Sud Lyon, France Institut Paoli Calmette Marseille, France Centre Val d'Aurelle Montpellier, France Clinique Valdegour-Centre médical Oncogard Nîmes, France Fondation Hôpital Saint Joseph Paris, France Hopital du Val de Grâce Paris, France Hôpital Européen Georges Pompidou Paris, France Centre Hospilier Universitaire de Poitiers Poitiers, France Institut Jean Godinot Reims, France Centre Eugène Marquis Rennes, France Centre René Gauducheau Saint Herblain, France Institut de Cancérologie de la Loire Saint Priest en Jarez, France Centre Hospitalier Starsbourg Strasbourg, France Hôpital FOCH Suresnes, France Institut Claudius Regaud Toulouse, France Centre Alexis Vautrin Vandoeuvre les Nancy, France Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00691730 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Not Applicable Active, not recruiting December 2018 Canada, Alberta ... More >> Tom Baker Cancer Centre Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario London Regional Cancer Program London, Ontario, Canada, N6A 4L6 Mount Sinai Hospital Toronto, Ontario, Canada, M5G 1X5 University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02208128 Renal Cell Carcinoma Not Applicable Unknown February 2018 Germany ... More >> Urological Department of the University Hospital Heidelberg Recruiting Heidelberg, Germany, 69120 Contact: Sascha Pahernik, PD Dr.    +49 6221 56 39689    sascha.pahernik@med.uni-heidelberg.de    Principal Investigator: Sascha Pahernik, PD Dr. Less <<
NCT02959554 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Active, not recruiting December 2021 Austria ... More >> Medizinische Universität Wien - Universitätsklinik für Innere Medizin I, Klinische Abteilung für Onkologie Wien, Austria, 1090 Germany Universitätsklinikum Essen (AöR) - Klinik und Poliklinik für Urologie / Kinderurologie und Uroonkologie Essen, Germany, 45147 Less <<
NCT00866320 - Completed - -
NCT01381614 - Completed - -
NCT01582009 - Terminated(pts off study, PI l... More >>eft institute) Less << - -
NCT00474786 Renal Cell Carcinoma Phase 3 Completed - -
NCT00953446 Renal Cell Carcinoma Not Applicable Suspended - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00474786 - Completed - -
NCT00866320 Kidney Cancer Phase 2 Completed - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 Less <<
NCT00979381 - Completed - Netherlands ... More >> University Medical Center Nijmegen st Radboud Nijmegen, Netherlands, 6525 GH Less <<
NCT00678288 - Terminated - -
NCT01603004 - Recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Nitya Raj, MD    646-888-4849       Contact: Kinh Gian Do, MD, PhD    212-639-8591       Principal Investigator: Nitya Raj, MD Less <<
NCT00543504 Advanced Cancer Phase 1 Active, not recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00538772 - Withdrawn - Canada, British Columbia ... More >> BC Cancer Agency - Centre for Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 BC Cancer Agency - Vancouver Vancouver, British Columbia, Canada, V5Z 4E6 BC Cancer Agency - Vancouver Island Victoria, British Columbia, Canada, V8R 6V5 Less <<
NCT00678288 Carcinoma, Renal Cell Phase 2 Terminated - Austria ... More >> Salzburg, Austria, 5020 Wien, Austria, 1090 France Avignon, France, 84000 Bayonne, France, 64100 Bordeaux, France, 33000 Marseille, France, 13015 Marseille, France, 13385 Nantes, France, 44020 Paris, France, 75014 Paris, France, 75651 Reims, France, 51100 Strasbourg, France, 67000 Toulouse, France, 31052 Vandoeuvre Les Nancy, France, 54000 Ireland Cork, Ireland Dublin, Ireland, 24 Italy Aviano, Pordenone, Italy, 33081 Legnago, Verona, Italy, 37045 Napoli, Italy, 80131 Pavia, Italy, 27100 Perugia, Italy, 06156 Reggio Emilia, Italy, 42100 Poland Gdansk, Poland, 80-219 Lublin, Poland, 20-090 Warszawa, Poland, 04-141 Wroclaw, Poland, 50 - 556 Spain Barcelona, Spain, 08035 Madrid, Spain, 28041 Madrid, Spain, 28046 Oviedo, Spain, 33006 Pamplona, Spain, 31008 Valencia, Spain, 46009 United Kingdom Northwood, Middlesex, United Kingdom, HA6 2RN Newcastle Upon Tyne, Tyne and Wear, United Kingdom, NE4 6BE London, United Kingdom, SW3 6JJ Less <<
NCT01254864 Prostate Cancer Phase 2 Active, not recruiting March 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00457691 Metastatic Colorectal Cancer Phase 3 Completed - -
NCT02688491 Renal Neoplasms ... More >> Targeted Molecular Therapy Less << Not Applicable Not yet recruiting July 2026 -
NCT00831857 - Completed - Netherlands ... More >> University Medical Center Groningen Groningen, Netherlands, 9700 RB Less <<
NCT01524848 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Denmark ... More >> Aarhus University Hospital, dept. of Oncology Aarhus, Denmark, DK-8000 Aarhus C Herlev Hospital, dept. of Oncology Herlev, Denmark, 2730 Finland Helsinki University Hospital, dept. of oncology Helsingfors, Finland, FI-00029 Kuopio University Hospital Cancer Center Kuopio, Finland, FI-70029 Germany Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg Berlin, Germany, 13125 Universitätsklinikum Essen, Innere klinik und Poliklinik Essen, Germany, DE-45122 Studienzentrale chirurgische klinik, Universitäts medizin Mannheim Mannheim, Germany, DE-68167 Norway Dept of Oncology, Haukeland University Hospital Bergen, Norway, N-5021 Norwegian Radium Hospital Oslo, Norway, N-0310 Dept of Oncology, St Olav Hospital Trondheim, Norway, N-7006 Sweden Dept of Oncology, Sahlgrenska University Hospital Gothenburg, Sweden, SE-413 45 Dept of Oncology, Linköping University Hospital Linköping, Sweden, SE-581 85 Dept of Oncology, Skane University Hospital Lund, Sweden, SE-221 85 Radiumhemmet, Karolinska University Hospital Stockholm, Sweden, SE-171 76 Dept of Oncology, Norrland University Hospital Umeå, Sweden, SE-901 85 Dept of Oncology, Academic Hospital Uppsala, Sweden, SE-751 85 Less <<
NCT03275558 Recurrent Glioblastoma ... More >> Gliosarcoma Anaplastic Gliomas Less << Phase 1 Withdrawn(Study halted prior t... More >>o enrollment of first participant. (It has been determined on 2018 May 15 that the NCT03275558 study will be stopped by sponsor decision)) Less << - Hong Kong ... More >> The Hong Kong Cancer Institute Hong Kong, Hong Kong, 518031 Singapore National University Cancer Institute, Singapore, Singapore, 119074 Less <<
NCT00869011 Renal Cell Carcinoma Phase 3 Unknown - Germany ... More >> Section Sports Medicine, Charité Universitätsmedizin Berlin, Hindenburgdamm 30 Recruiting Berlin, Germany, 12200 Contact: Fernando C. Dimeo, MD    +493084452098    fernando.dimeo@charite.de    Principal Investigator: Fernando C. Dimeo, MD Less <<
NCT00734851 - Terminated(Dose Limiting Toxic... More >>ities) Less << - -
NCT00444795 - Completed - Korea, Republic of ... More >> Keimyung University Dongsan Medical Center Jung-gu, Daegu, Korea, Republic of, 100-712 Daegu Catholic University Medical Center Nam-gu, Daegu, Korea, Republic of, 705-718 GangNeung Asan Hospital Gangneung-si, Gangwon-do, Korea, Republic of, 210-711 Soonchunhyang University Bucheon Hospital Bucheon, Gyeonggi-do, Korea, Republic of, 420-767 The Catholic University of Korea, St. Vincent's Hospital Suwon, Gyeonggi-do, Korea, Republic of, 442-723 Hwasun Hospital, Chonnam National University Cheonnam, South Jeolla Province, Korea, Republic of, 519-809 Hallym University Sacred Heart Hospital Anyang, Korea, Republic of, 431-070 Pusan National University Hospital Busan, Korea, Republic of, 602 739 Kosin University Gospel Hospital Busan, Korea, Republic of, 602-702 Dong-A University Hospital Busan, Korea, Republic of, 602-715 Dong-A University Medical Center (Dong-A University Hospital) Busan, Korea, Republic of, 602-715 Dong-A University Medical Center, Department of Medicine, Division of Hemato-Oncology Busan, Korea, Republic of, 602-715 Pusan National University Hospital Busan, Korea, Republic of, 602-739 Hwasun Hospital, Chonnam National University Cheonnam, Korea, Republic of, 519-809 Keimyung University Dongsan Hospital Daegu, Korea, Republic of, 700 712 Kyungpook National University Medical Center Daegu, Korea, Republic of, 702-210 Daegu Catholic University Medical Center (DCUMC) Daegu, Korea, Republic of, 705-718 Chungnam National University Hospital Daejeon, Korea, Republic of, 301-721 Eulji University Hospital Daejeon, Korea, Republic of, 302-799 Inje University Ilsan Paik Hospital Goyang, Korea, Republic of, 411-706 Chosun University Hospital Gwang Joo, Korea, Republic of, 501-717 Pusan National University Hospital Gyeongsangnam-do, Korea, Republic of, 626-770 Wonkwang University School of Medicine and Hospital (WUH) Iksan -Si, Korea, Republic of Inha University Hospital Incheon, Korea, Republic of, 400-711 Gachon University Gil Hospital Incheon, Korea, Republic of, 405-760 Chonbuk National University Hospital Jeonju, Korea, Republic of, 561-712 Yeungnam University Medical Center Nam-gu, Korea, Republic of, 705-717 Seoul National University Bundang Hospital Seongnam-si, Korea, Republic of, 463-707 Seoul National University Hospital (SNUH) Seoul, Korea, Republic of, 110-744 Seoul National University Hospital / Department of Internal Medicine Seoul, Korea, Republic of, 110-744 Kangbuk Samsung Hospital Seoul, Korea, Republic of, 110-746 Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 120-752 Kyung Hee University Medical Center Seoul, Korea, Republic of, 130-872 KyungHee University Medical Center Seoul, Korea, Republic of, 130-872 Samsung Medical Center, Dept. of Medicine, Div. of Hematology/Oncology Seoul, Korea, Republic of, 135-710 Samsung Medical Center/Division of Hematology-Oncology, Department of Medicine Seoul, Korea, Republic of, 135-710 Gangnam Severance Hospital, Yonsei University Health System Seoul, Korea, Republic of, 135-720 Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Asan Medical Center/Department of Oncology Seoul, Korea, Republic of, 138-736 Asan Medical Center Seoul, Korea, Republic of, 138-736 Korea Cancer Center Hospital Seoul, Korea, Republic of, 139-706 Korea University Guro Hospital Seoul, Korea, Republic of, 152-703 Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of, 158-710 Seoul National University Hospital Seoul, Korea, Republic of, 3080 Seoul ST. Mary's Hospital Seoul, Korea, Republic of Ulsan University Hospital Ulsan, Korea, Republic of, 682-714 Yonsei University Wonju College of Medicine, Wonju Christian Hospital Wonju-si, Korea, Republic of, 220-701 Less <<
NCT00688766 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Terminated(Based on Independen... More >>t Data Monitoring Committee (IDMC) recommendation.) Less << - -
NCT00457691 - Completed - -
NCT02324803 Self Efficacy ... More >> Adverse Drug Event Carcinoma, Renal Cell Less << Phase 2 Unknown December 2015 China, Guangdong ... More >> The First Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China, 510120 Contact: Mian Xie Less <<
NCT01381601 - Completed - -
NCT00734851 Prostate Cancer Phase 2 Terminated(Dose Limiting Toxic... More >>ities) Less << - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21218 United States, New Jersey The Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08901 United States, North Carolina Duke University Durham, North Carolina, United States, 27705 Less <<
NCT00444795 - Completed - -
NCT01289028 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 155226 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45122 Novartis Investigative Site Frankfurt, Germany, 60488 Novartis Investigative Site Freiburg, Germany, 79106 Novartis Investigative Site Halle/'Saale, Germany, 06120 Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Novartis Investigative Site Muenchen, Germany, 81675 Novartis Investigative Site Ulm, Germany, 89081 Italy Novartis Investigative Site Bologna, BO, Italy, 40138 Novartis Investigative Site Genova, GE, Italy, 16132 Novartis Investigative Site Taormina, ME, Italy, 98039 Novartis Investigative Site Milano, MI, Italy, 20133 Novartis Investigative Site Padova, PD, Italy, 35100 Novartis Investigative Site Aviano, PN, Italy, 33081 Novartis Investigative Site Torino, TO, Italy, 10153 Less <<
NCT00705874 Cancer Phase 1 Completed - United States, Colorado ... More >> Rocky Mountain Cancer Centre Denver, Colorado, United States United States, Florida Cancer Centres of Florida Ocoee, Florida, United States, 34761 United States, Indiana Central Indiana Cancer Centres Indianapolis, Indiana, United States, 46219 United States, Nevada Comprehensive Cancer Centres of Nevada Las Vegas, Nevada, United States, 89169 United States, New York New York Oncology Hematology PC Albany, New York, United States, 12206 United States, Ohio Dayton Oncology and Hematology, PA Kettering, Ohio, United States, 45409 United States, South Carolina Cancer Centres of the Carolinas Greenville, South Carolina, United States, 29605 United States, Texas Texas Oncology, PA Dallas, Texas, United States, 75246 Tyler Cancer Centre Tyler, Texas, United States, 75702 United States, Virginia Virginia Oncology Associates Norfolk, Virginia, United States, 23502 United States, Washington Northwest Cancer Specialists - Vancouver Cancer Centre Vancouver, Washington, United States, 98684 North Star Lodge Cancer Centre Yakima, Washington, United States, 98902 Less <<
NCT00705874 - Completed - -
NCT00700258 - Recruiting December 1, 2023 -
NCT00717587 Kidney Cancer Phase 2 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104-4283 Contact: Clinical Trials Office - Abramson Cancer Center of the Univers    800-474-9892 Less <<
NCT01514448 Metastatic Renal Cell Carcinom... More >>a (mRCC) Less << Phase 4 Completed - Germany ... More >> Novartis Investigative Site Chemnitz, Germany, 09130 Novartis Investigative Site Dresden, Germany, 01307 Novartis Investigative Site Hannover, Germany, 30559 Novartis Investigative Site Hof, Germany, 95028 Novartis Investigative Site Kassel, Germany, 34125 Novartis Investigative Site Langen, Germany, 63225 Novartis Investigative Site Leipzig, Germany, 04357 Novartis Investigative Site Magdeburg, Germany, 39120 Novartis Investigative Site Muenster, Germany, 48149 Novartis Investigative Site Ravensburg, Germany, 88214 Novartis Investigative Site Velbert, Germany, 42551 Novartis Investigative Site Wiesbaden, Germany, 65191 Novartis Investigative Site Wolfsburg, Germany, 38440 Less <<
NCT00486538 Advanced Renal Cell Carcinoma Phase 2 Completed - United States, California ... More >> Site Reference ID/Investigator# 7193 Sacramento, California, United States, 95817 United States, District of Columbia Site Reference ID/Investigator# 5243 Washington, District of Columbia, United States, 20010 United States, Illinois Site Reference ID/Investigator# 5384 Chicago, Illinois, United States, 60637 United States, Massachusetts Site Reference ID/Investigator# 11662 Boston, Massachusetts, United States, 02114 Site Reference ID/Investigator# 11663 Boston, Massachusetts, United States, 02114 Site Reference ID/Investigator# 5379 Boston, Massachusetts, United States, 02114 United States, New Hampshire Site Reference ID/Investigator# 5380 Lebanon, New Hampshire, United States, 03756-0001 United States, Pennsylvania Site Reference ID/Investigator# 5249 Philadelphia, Pennsylvania, United States, 19111 Site Reference ID/Investigator# 6278 Philadelphia, Pennsylvania, United States, 19111 Site Reference ID/Investigator# 6269 Pittsburgh, Pennsylvania, United States, 15232 United States, South Carolina Site Reference ID/Investigator# 7300 Charleston, South Carolina, United States, 29425 United States, Texas Site Reference ID/Investigator# 6796 Houston, Texas, United States, 77030-4009 Canada Site Reference ID/Investigator# 6566 Vancouver, Canada, V5Z 4E6 Less <<
NCT01514448 - Completed - -
NCT02535351 Clear-cell Metastatic Renal Ce... More >>ll Carcinoma Less << Phase 3 Terminated(low enrolment) - Italy ... More >> Fondazione IRCCS Istituto Nazionale Tumori Milan, Mi, Italy, 20133 Less <<
NCT00265798 - Active, not recruiting - -
NCT00265798 Gastrointestinal Stromal Tumor Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00861419 Advanced Solid Tumors Phase 1 Completed - -
NCT01289028 - Completed - -
NCT01227213 - Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Netherlands, 6500HB Less <<
NCT03260894 Renal Cell Carcinoma (RCC) Phase 3 Active, not recruiting June 2020 -
NCT01091207 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135710 Less <<
NCT00509704 - Completed - Netherlands ... More >> UMC St Radboud Nijmegen, Netherlands Less <<
NCT00482755 Breast Cancer Phase 2 Completed - Canada, British Columbia ... More >> British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada, V5Z 4E6 Canada, Ontario Edmond Odette Cancer Centre at Sunnybrook Toronto, Ontario, Canada, M4N 3M5 Less <<
NCT01370109 - Completed - United States, Pennsylvania ... More >> Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT01099423 Kidney Cancer Phase 3 Active, not recruiting May 2017 Belgium ... More >> Onze Lieve Vrouw Ziekenhuis Aalst, Belgium Cliniques Universitaires St. Luc Brussels, Belgium Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium Universitair Ziekenhuis Gent Gent, Belgium Virga Jesse Hospital Hasselt, Belgium AZ Groeninghe - Campus Loofstraat Kortrijk, Belgium AZ Damiaan - Campus Sint-Jozef Oostende, Belgium Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada Canada, Quebec CHUM - Pavillon Saint-Luc Montreal,, Quebec, Canada Canada Montreal General Hospital Montreal, Canada The Ottawa Hospital, The Integrated Cancer Program- General Campus Ottawa, Canada University Health Network - Oci / Princess Margaret Hospital Toronto, Canada Diamond Health Care Centre Vancouver, Canada Italy San Camillo Forlanini Hospitals Roma, Italy Netherlands Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands Academisch Medisch Centrum - Universiteit van Amsterdam Amsterdam, Netherlands The Netherlands Cancer Institute-Antoni Van Leeuwenhoekziekenhuis Amsterdam, Netherlands Vrije Universiteit Medisch Centrum Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Academisch Ziekenhuis Maastricht Maastricht, Netherlands Radboud University Nijmegen Medical Centre Nijmegen, Netherlands Universitair Medisch Centrum - Academisch Ziekenhuis Utrecht, Netherlands United Kingdom Royal United Hospital Bath, United Kingdom University Hospitals Bristol NHS Foundation Trust - Bristol Haematology And Oncology Centre Bristol, United Kingdom St. James'S University Hospital Leeds, United Kingdom Barts and The London NHS Trust - St. Bartholomew'S Hospital London, United Kingdom Imperial College Healthcare NHS Trust - Charing Cross Hospital London, United Kingdom Christie NHS Foundation Trust Manchester, United Kingdom Singelton Hospital Swansea, United Kingdom Less <<
NCT01876212 Metastatic Melanoma Phase 2 Active, not recruiting June 6, 2019 United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT02645149 Melanoma Phase 4 Not yet recruiting August 2021 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Not yet recruiting Camperdown, New South Wales, Australia, 2050 Contact: Maria Gonzalez    612 9911 7200    maria.gonzalez@melanoma.org.au    Principal Investigator: John Thompson          Westmead Hospital Westmead, New South Wales, Australia, 2145 Melanoma Institute Australia Not yet recruiting Wollstonecraft, New South Wales, Australia, 2065 Contact: Maria Gonzalez    +612 9911 7200    maria.gonzalez@melanoma.org.au    Contact: Alex Menzies    +612 9911 7200    info@melanoma.org.au    Sub-Investigator: Georgina Long          Principal Investigator: Alex Menzies Less <<
NCT00610012 - Active, not recruiting August 2020 Germany ... More >> iOMEDICO Freiburg, Germany Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT01246817 Renal Cell Cancer Phase 2 Unknown - Netherlands ... More >> University Medical Centre Nijmegen Recruiting Nijmegen, Gelderland, Netherlands, 6500 HB Principal Investigator: C.M.L. van Herpen, Md PhD Less <<
NCT01758575 - Terminated - Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands, 1081HV Less <<
NCT00877045 - Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30341 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 Less <<
NCT03419572 - Recruiting January 5, 2021 -
NCT02776644 - Completed - -
NCT00601120 Renal Cell Carcinoma Not Applicable Withdrawn(This protocol was ne... More >>ver officially opened and no patients were recruited.) Less << - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT01984931 Nausea Vomiti... More >>ng Less << Phase 3 Unknown December 2013 Korea, Republic of ... More >> Chungmu General Hopsital Recruiting Seoul, Yeongdeungpo-gu, Korea, Republic of, 150-034 Contact: Sang Hoon Lhee, MD, Phd    +82 (2) 2068/4525    cmirb@naver.com    Principal Investigator: Paolo Alan B Tabar, MD Less <<
NCT02208583 Hormone Refractory Prostate Ca... More >>ncer Less << Not Applicable Unknown December 2016 China, Tianjin ... More >> Department of Interventional Oncology, Tianjin Medical University Cancer Institute and Hospital Recruiting Tianjin, Tianjin, China, 300060 Contact: Wang HaiTao, Ph.D    +86-18630955984    peterrock2000@126.com    Principal Investigator: Wang HaiTao, Ph.D Less <<
NCT03387514 Renal Cell Carcinoma Phase 2 Recruiting January 15, 2022 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Cancer Connect    800-622-8922    cancerconnect@uwcarbone.wisc.edu Less <<
NCT01636908 Cancer Advanc... More >>ed Solid Tumors Less << Not Applicable Active, not recruiting - Netherlands ... More >> VUMedical Center Amsterdam, Netherlands, 1081 HV Less <<
NCT02142036 Metastatic Cancer Phase 2 Active, not recruiting January 2022 Norway ... More >> Akershus University Hospital Lillestrøm, Norway, 1478 The Norwegian Radium Hospital Oslo, Norway, 0379 Less <<
NCT03413176 - Completed - France ... More >> AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM. Paris, France, 75013 Less <<
NCT00698659 - Terminated - Singapore ... More >> National University Hospital Singapore, Singapore Less <<
NCT03297606 Lymphoma, Non-Hodgkin ... More >> Multiple Myeloma Advanced Solid Tumors Less << Phase 2 Recruiting September 2021 Canada, British Columbia ... More >> BCCA - Vancouver Cancer Centre Recruiting Vancouver, British Columbia, Canada, V5Z 4E6 Contact: Daniel John Renouf    604 877-6000 ext 672357       Canada, Ontario London Regional Cancer Program Recruiting London, Ontario, Canada, N6A 5W9 Contact: Stephen Welch    519 685-8640       Ottawa Hospital Research Institute Recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: John Hilton    613 737-7700 ext 70179       University Health Network Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Lillian Siu    416 946-2911       Canada, Quebec The Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 Contact: Cristiano Ferrario    514 398-8307 Less <<
NCT01200134 Anaplastic Glioma Phase 2 Completed - France ... More >> Caen University Hospital Caen, France, 14033 Less <<
NCT02747173 - Terminated - Spain ... More >> Hospital Universitario central de Asturias Oviedo, Asturias, Spain, 33011 Hospital de Donostia San Sebastián, Guipuzcoa, Spain, 20080 Complejo Hospitalario Univ de Santiago de Compostela Santiago de Compostela, La Coruña, Spain, 15706 Hospital de Navarra Pamplona, Navarra, Spain, 31008 Complejo Hospitalario Univ de Vigo Vigo, Pontevedra, Spain, 36204 Consorcio Hospitalario Parc Tauli Barcelona, Spain, 08208 Complejo Hospitalario de León Leon, Spain, 24071 Hospital Univ Lucus Augusti Lugo, Spain, 27003 Complejo Hospitalario de Ourense Ourense, Spain, 32005 Instituto Valenciano de Oncologia Valencia, Spain, 46009 Hospital Universitario La Fe Valencia, Spain, 46026 Hospital Miguel Servet Zaragoza, Spain, 50009 Less <<
NCT01858441 Pharmacogenetic Study Not Applicable Active, not recruiting December 2020 France ... More >> Centre Antoine Lacassagne Nice, France, 06000 Less <<
NCT02228954 - Active, not recruiting December 2019 Netherlands ... More >> VU University Medical Center Amsterdam, Netherlands University Medical Center Groningen Groningen, Netherlands Radboudumc Nijmegen, Netherlands, 6525GA Less <<
NCT02086734 - Completed - Germany ... More >> Urologische Klinik und Poliklinik der Universität München München, Bavaria, Germany, 81377 Less <<
NCT00498966 Kidney Cancer Phase 2 Completed - United States, Kentucky ... More >> Investigative Site Louisville, Kentucky, United States, 40202 United States, New Jersey Investigative Site Morristown, New Jersey, United States, 07962 United States, New York Investigative Site Armonk, New York, United States, 10504 Less <<
NCT01810744 Metastatic Colorectal Cancer ... More >> Glioblastoma Bevacizumab Capillaroscopy Less << Not Applicable Active, not recruiting June 2018 France ... More >> Centre Georges François Leclerc Dijon, France, 21079 Less <<
NCT01498458 Metastatic Breast Cancer Phase 1 Completed - Germany ... More >> GBG Forschungs GmbH Neu-Isenburg, Germany, 63263 Less <<
NCT01498458 - Completed - -
NCT03091465 - Completed - -
NCT02847377 Carcinoma, Non-Small-Cell Lung Early Phase 1 Recruiting March 27, 2019 France ... More >> CGFL Recruiting Dijon, France, 21079 Less <<
NCT01538238 Locally Advanced or Metastatic... More >> Non-clear Cell Type Renal Cell Carcinoma Less << Phase 2 Completed - Korea, Republic of ... More >> Samsung medical Center Seoul, Korea, Republic of Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02044354 Metastatic Castration-resistan... More >>t Prostate Cancer Less << Phase 3 Active, not recruiting April 2018 France ... More >> Gustave Roussy Villejuif, Val de Marne, France, 94805 Less <<
NCT01372813 - Terminated(Terminated for insu... More >>fficient accrual.) Less << - -
NCT02056587 Metastatic Renal Cell Carcinom... More >>a Less << Phase 4 Completed - Russian Federation ... More >> Tatarstan Regional Cancer Center Kazan, Tatarstan, Russian Federation, 420029 Altai Regional Cancer Center Barnaul, Russian Federation N.N. Blokhin Russian Cancer Research Center Moscow, Russian Federation, 115478 Less <<
NCT03024437 Metastatic Cancer ... More >> Renal Cancer Less << Phase 1 Phase 2 Recruiting January 31, 2020 United States, Indiana ... More >> Indiana University Health Hospital Recruiting Indianapolis, Indiana, United States, 46202 Contact: Sheila Dropcho, RN    317-278-4191    marlmoor@iu.edu    Principal Investigator: Roberto Pili, MD          Indiana University Melvin and Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Sheila Dropcho, RN    317-278-4191    sdropcho@iupui.edu    Principal Investigator: Roberto Pili, MD          United States, Pennsylvania University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Julia Wolinkski    215-360-0928    julia.wolinksi@uphs.upenn.edu    Principal Investigator: Vivek Narayan, MD Less <<
NCT01466504 - Terminated(Accrual did not mee... More >>t expectations. Over nearly 2 years just 4 subjects were treated on study. The goal of 30 subjects was not attainable.) Less << - United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center, Norris Cotton Cancer Center Lebanon, New Hampshire, United States, 03756 United States, Vermont White River Junction VA Medical Center White River Junction, Vermont, United States, 05009 Less <<
NCT03229512 Hand Foot Skin Reaction Early Phase 1 Recruiting December 2018 United States, Illinois ... More >> Department of Dermatology, Northwestern University Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD    312-695-8106    jennifer.choi@northwestern.edu    Contact: Linda Serrano, MD    312-503-5903    linda.serrano@northwestern.edu    Principal Investigator: Jennifer N Choi, MD          Sub-Investigator: Linda Serrano, MD          Northwestern Memorial Hospital Recruiting Chicago, Illinois, United States, 60611 Contact: Jennifer N Choi, MD    312-695-8106    jennifer.choi@northwestern.edu    Contact: Linda Serrano, MD    312-503-5903    linda.serrano@northwestern.edu    Principal Investigator: Jennifer N Choi, MD          Sub-Investigator: Linda Serrano, MD Less <<
NCT02877368 - Completed - France ... More >> Chu de Reims Reims, France, 51092 Less <<
NCT01372813 Advanced Clear Cell Renal Carc... More >>inoma Less << Phase 2 Terminated(Terminated for insu... More >>fficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02712112 Gastrointestinal Stromal Tumor... More >>s (GISTs) Less << Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Min-Hee Ryu, MD., Ph.D.    +82-10-5285-9492    miniryu@amc.seoul.kr    Principal Investigator: Min-Hee Ryu, M.D., Ph.D. Less <<
NCT00715182 Advanced/ Metastatic Renal Cel... More >>l Cancer Less << Phase 1 Completed - United States, California ... More >> Novartis Investigative Site San Francisco, California, United States United States, North Carolina Novartis Investigative Site Durham, North Carolina, United States, 27710 United States, Washington Novartis Investigative Site Seattle, Washington, United States, 98109-1023 France Novartis Investigative Site Bordeaux Cedex, France, 33075 Novartis Investigative Site Villejuif Cedex, France, 94805 Germany Novartis Investigative Site Hannover, Germany, 30625 Novartis Investigative Site München, Germany, 81675 Netherlands Novartis Investigative Site Rotterdam, Netherlands, 3075 EA Spain Novartis Investigative Site Madrid, Spain, 28041 Taiwan Novartis Investigative Site Taipei, Taiwan, ROC, Taiwan, 112 Novartis Investigative Site Taichung, Taiwan, 40705 Novartis Investigative Site Taipei, Taiwan, 10002 Less <<
NCT01339962 - Completed - Denmark ... More >> University of Copenhagen Herlev Hospital Herlev, Denmark, 2730 Less <<
NCT02599779 Stage IV Renal Cell Cancer AJC... More >>C V7 Less << Phase 2 Recruiting March 2021 Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Richard Lee-Ying, MD       richard.lee-ying@albertahealthservices.ca    Principal Investigator: Richard Lee-Ying, MD          Canada, Ontario Sunnybrook Health Sciences Centre Recruiting Toronto, Ontario, Canada, M4N 3M5 Contact: Georg A. Bjarnason, MD    416-480-5847    georg.bjarnason@sunnybrook.ca    Contact: Nesan Bandali, RN    416-480-5000 ext 82139    nesan.bandali@sunnybrook.ca    Principal Investigator: Georg A. Bjarnason, MD          Princess Margaret Hospital Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Aaron Hansen, MD    416-946-4501    aaron.hansen@uhn.ca    Principal Investigator: Aaron Hansen, MD Less <<
NCT00782275 - Completed - -
NCT02558387 Recurrent or Metastatic Saliva... More >>ry Gland Cancer of the Head and Neck Less << Phase 2 Unknown January 2017 Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of, 135-710 Less <<
NCT01798446 Renal Cell Carcinoma ... More >> Nonclear Cell Temsirolimus Resistance Less << Phase 2 Unknown December 2016 Korea, Republic of ... More >> Seou National University Hospital Recruiting Seoul, Korea, Republic of, 110744 Contact: Se-Hoon Lee, MD, PhD    82220722199    shlee119@snu.ac.kr    Principal Investigator: Se-Hoon Lee, MD, PhD          Sub-Investigator: Dae Seog Heo, MD, PhD          Sub-Investigator: Dong-Wan Kim, MD, PhD          Sub-Investigator: Tae Min Kim, MD, PhD          Sub-Investigator: Bhumsuk Keam, MD Less <<
NCT02693535 Lymphoma, Non-Hodgkin ... More >> Multiple Myeloma Advanced Solid Tumors Less << Phase 2 Recruiting - -
NCT00782275 Renal Cell Carcinoma ... More >> Kidney Cancer Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Tennessee Vanderbilt Univeristy Medical Center Nashville, Tennessee, United States, 37232 Less <<
NCT02113826 Metastatic Alveolar Soft Part ... More >>Sarcoma Less << Phase 2 Terminated(Low accrual rate) - Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT02816515 - Completed - Hungary ... More >> Department of Oncological Internal Medicine and Clinical Pharmacology "C", National Institute of Oncology Hungary Budapest, Hungary, 1026 National Koranyi Institute of TB and Pulmonology Budapest, Hungary, 1121 National Institute of Oncology, Department of Radiotherapy 7-9 Ráth György u. Budapest, Hungary Less <<
NCT01342627 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(low enrollment rate... More >>) Less << - Italy ... More >> Centro di Riferimento Oncologico Aviano, Pordenone, Italy, 33081 Less <<
NCT01491672 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center NY, New York, United States, 90033 Argentina Novartis Investigative Site Rio Negro, Viedma, Argentina, 8500 Novartis Investigative Site Tucuman, Argentina, T4000 Brazil Novartis Investigative Site Florianopolis, SC, Brazil, 88034-000 Novartis Investigative Site Barretos, SP, Brazil, 14784-400 Novartis Investigative Site São Paulo, SP, Brazil, 01246-000 Novartis Investigative Site São Paulo, SP, Brazil, 01509-900 Bulgaria Novartis Investigative Site Sofia, Bulgaria, 1784 China, Beijing Novartis Investigative Site Beijing, Beijing, China, 100730 China, Zhejiang Novartis Investigative Site Hangzhou, Zhejiang, China, 310003 China Novartis Investigative Site Beijing, China, 100021 Novartis Investigative Site Guangzhou, China, 510060 Novartis Investigative Site Shanghai, China, 200032 Russian Federation Novartis Investigative Site Leningrad Region, Russia, Russian Federation, 188663 Novartis Investigative Site Moscow, Russia, Russian Federation, 125284 Novartis Investigative Site Nizhny Novgorod, Russia, Russian Federation, 603001 Novartis Investigative Site Obninsk, Russia, Russian Federation, 249036 Less <<
NCT02465060 Advanced Malignant Solid Neopl... More >>asm Bladder Carcinoma Breast Carcinoma Cervical Carcinoma Colon Carcinoma Colorectal Carcinoma Endometrial Carcinoma Esophageal Carcinoma Gastric Carcinoma Glioma Head and Neck Carcinoma Kidney Carcinoma Liver and Intrahepatic Bile Duct Carcinoma Lung Carcinoma Lymphoma Malignant Uterine Neoplasm Melanoma Ovarian Carcinoma Pancreatic Carcinoma Plasma Cell Myeloma Prostate Carcinoma Rectal Carcinoma Recurrent Bladder Carcinoma Recurrent Breast Carcinoma Recurrent Cervical Carcinoma Recurrent Colon Carcinoma Recurrent Colorectal Carcinoma Recurrent Esophageal Carcinoma Recurrent Gastric Carcinoma Recurrent Glioma Recurrent Head and Neck Carcinoma Recurrent Liver Carcinoma Recurrent Lung Carcinoma Recurrent Lymphoma Recurrent Malignant Solid Neoplasm Recurrent Melanoma Recurrent Ovarian Carcinoma Recurrent Pancreatic Carcinoma Recurrent Plasma Cell Myeloma Recurrent Prostate Carcinoma Recurrent Rectal Carcinoma Recurrent Skin Carcinoma Recurrent Thyroid Gland Carcinoma Recurrent Uterine Corpus Carcinoma Refractory Lymphoma Refractory Malignant Solid Neoplasm Refractory Plasma Cell Myeloma Skin Carcinoma Thyroid Gland Carcinoma Uterine Corpus Cancer Less << Phase 2 Recruiting - -
NCT01491672 - Completed - -
NCT03556384 Gastrointestinal Stromal Tumor... More >>s Sdh GIST Cancer Less << Phase 2 Recruiting September 2024 United States, California ... More >> UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Elaine Eng       e1eng@ucsd.edu    Principal Investigator: Adam M Burgoyne, MD, PhD          Sub-Investigator: Jason K Sicklick, MD Less <<
NCT02751827 - Recruiting February 2019 France ... More >> Institut Bergonié Recruiting Bordeaux, France, 33076 Contact: Antoine ITALIANO, MD,PhD          Principal Investigator: Antoine ITALIANO, MD,PhD          Centre Léon Bérard Not yet recruiting Lyon Cedex 08, France, 69373 Contact: Jean-Yves BLAY, MD, PhD          Principal Investigator: Jean-Yves BLAY, MD, PhD Less <<
NCT02789137 - Recruiting October 30, 2018 Spain ... More >> Hospital Arquitecto Marcide de Ferrol Recruiting Ferrol, A Coruña, Spain, 15405 Hospital Asil de Granollers Recruiting Granollers, Barcelona, Spain, 08402 Hospital Parc Taulí Recruiting Sabadell, Barcelona, Spain, 08208 Hospital Galdakano Recruiting Usansolo, Bizkaia, Spain, 48960 Complejo Hospitalario la Mancha Centro Recruiting Alcazar de San Juan, Ciudad REAL, Spain, 13600 Hospital Universitari Son Espases Recruiting Palma, Mallorca, Spain, 07120 H. Universitario Infanta Cristina Recruiting Badajoz, Spain, 06006 Hospital Vall de Hebrón Recruiting Barcelona, Spain, 08035 Hospital Universitario Ciudad Real Recruiting Ciudad Real, Spain, 13005 H. Reina Sofía de Cordoba Recruiting Córdoba, Spain, 14004 Hospital de Cabueñes Not yet recruiting Gijón, Spain, 33394 ICO Girona (Hospital Dr.Josep Trueta) Recruiting Girona, Spain, 17007 Hospital Universitario de Guadalajara Not yet recruiting Guadalajara, Spain, 19002 Complejo Hospitalario de Jaén Recruiting Jaén, Spain, 23007 Complejo Hospitalario de León Recruiting León, Spain, 24071 Complejo Hospitalario Ourense. Hospital Santa María Nai Recruiting Ourense, Spain, 32005 Hospital General de Asturias Not yet recruiting Oviedo, Spain, 33011 Complejo Hospitalario de Navarra Recruiting Pamplona, Spain, 31008 Hospital Universitario Canarias Not yet recruiting Santa Cruz de Tenerife, Spain, 38320 Hospital de Sant Pau i Santa Tecla Recruiting Tarragona, Spain, 43003 Hospital Virgen de la Salud Recruiting Toledo, Spain, 45071 Hospital Clínico Universitario de Valencia Recruiting Valencia, Spain, 46011 H Clínico Zaragoza Recruiting Zaragoza, Spain, 50009 Less <<
NCT01390519 - Completed - Norway ... More >> Novartis Investigative Site Kristiansand, Norway, 4615 Novartis Investigative Site Tromsø, Norway, 9038 Novartis Investigative Site Trondheim, Norway, 7006 Less <<
NCT03353753 Gastrointestinal Stromal Tumor... More >>s Less << Phase 3 Active, not recruiting December 2020 -
NCT01370980 - Unknown September 2014 Switzerland ... More >> Policlinique Médicale Universitaire and Centre pluridisciplinaire d'oncologie, CHUV Recruiting Lausanne, Vaud, Switzerland, 1010 Contact: Bugnon Olivier    +41 21 314 48 48    Olivier.Bugnon@hospvd.ch    Contact: Schneider Marie-Paule    +41 21 314 48 46    Marie-Paule.Schneider@hospvd.ch Less <<
NCT01377298 Head and Neck Squamous Cell Ca... More >>rcinoma Less << Phase 2 Unknown May 2014 Taiwan ... More >> National Taiwan University Hospital Recruiting Taipei, Taiwan, 100 Contact: Ruey-Long Hong, MD    +886 2 23123456 ext 67510    rlhong@ntu.edu.tw    Sub-Investigator: Jo-Pai Chen, MD          Principal Investigator: Ruey-Long Hong, MD Less <<
NCT00633295 Gastrointestinal Stromal Tumor... More >>s (GIST) Less << Phase 2 Completed - Israel ... More >> Novartis Investigative Site Jerusalem, Israel Novartis Investigative Site Tel Aviv, Israel Novartis Investigative Site Tel Hashomer, Israel Less <<
NCT02338570 Renal Cell Carcinoma Phase 4 Terminated(Stopped on November... More >> 16th 2016, because of recruitment failure.) Less << - Italy ... More >> Spedali Civili Brescia, Italy Ospedale A Perrino Brindisi, Italy Istituto Europeo di Oncologia Milano, Italy Istituto Nazionale Tumori - IRCCS Fondazione G. Pascale Napoli, Italy AOU Maggiore della Carità Novara, Italy Casa di Cura La Maddalena Palermo, Italy Unicampus Biomedico Roma, Italy AOU San Giovanni di Dio e Ruggi D'Aragona Salerno, Italy Less <<
NCT02700568 Carcinoma, Renal Cell ... More >> Clear Cell Renal Cell Carcinoma Less << Phase 2 Recruiting August 2018 Russian Federation ... More >> Demchenkova Marina Viktorovna Recruiting Irkutsk, Russian Federation Semenov Andrey Vladimirovich Recruiting Ivanovo, Russian Federation Mikhailova Nadezhda Vasilievna Recruiting Kazan, Russian Federation Eskerov Kurban Abdulmutalibovich Active, not recruiting Kirov, Russian Federation Zukov Ruslan Aleksandrovich Recruiting Krasnoyarsk, Russian Federation Ovchinnikova Elena Georgievna Recruiting Nizhny Novgorod, Russian Federation Guseva Irina Vasilievna Recruiting Penza, Russian Federation Vladimirova Lyubov Yur'evna Active, not recruiting Rostov-on-Don, Russian Federation Zolotoreva Tatiana Gennadievna Recruiting Samara, Russian Federation Katkov Alexey Aleksandrovich Active, not recruiting Saratov, Russian Federation Ivannikov Andrey Andreyevich Recruiting Tambov, Russian Federation Usynin Evgeny Anatolievich Recruiting Tomsk, Russian Federation Evstegneyeva Irina Vladimirovna Recruiting Tver, Russian Federation Khmelevsky Andrey Anatolievich Recruiting Ufa, Russian Federation Gurina Ludmila Ivanovna Active, not recruiting Vladivostok, Russian Federation Less <<
NCT03185039 Kidney Cancer Not Applicable Recruiting November 29, 2020 France ... More >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: GENRE Dominique, MD    33 (0)4 91 22 37 78    drci.up@ipc.unicancer.fr    Contact: Isabelle Boquet, PhD    33 (0)4 91 22 37 78    drci.up@ipc.unicancer.fr    Principal Investigator: GRAVIS Gwénaëlle, MD Less <<
NCT00923130 - Completed - -
NCT02921724 Cancer Oral D... More >>rug Administration Less << Not Applicable Recruiting May 2019 Italy ... More >> Azienda Ospedaliera Papa Giovanni XXIII, Bergamo Recruiting Bergamo, Italy, 24127 Contact: Carlo Tondini, MD          Principal Investigator: Carlo Tondini, MD          Irst-Irccs Recruiting Meldola (FC), Italy, 47014 Contact: Alessandro Passardi, MD    +39 0543 739238    alessandro.passardi@irst.emr.it    Principal Investigator: Alessandro Passardi, MD          Azienda Provinciale per i Servizi Sanitari della Provincia Autonoma di Trento Recruiting Trento, Italy, 38123 Contact: Mimma Rizzo, MD          Principal Investigator: Mimma Rizzo, MD Less <<
NCT00448721 Renal Cell Carcinoma Phase 2 Completed - United States, California ... More >> Investigative Site Duarte, California, United States, 91010 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Pennsylvania Investigative Site Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Investigative Site Nashville, Tennessee, United States, 37232 Less <<
NCT02483247 Cancer Phase 1 Phase 2 Active, not recruiting - United States, Indiana ... More >> Parkview Research Center Fort Wayne, Indiana, United States Indiana University Health Goshen Goshen, Indiana, United States, 46526 Indiana University -Ball Indianapolis, Indiana, United States Indiana University-SCC Indianapolis, Indiana, United States United States, Louisiana Louisiana State Univesity New Orleans, Louisiana, United States United States, Virginia US Oncology Research Fairfax, Virginia, United States Canada, Ontario Ottawa Hospital Research Institute Ottawa, Ontario, Canada Princess Margaret Cancer Centre Toronto, Ontario, Canada Less <<
NCT01265810 Oral Complaints ... More >> Renal Cell Carcinoma Hepatocellular Carcinoma Gastrointestinal Stromal Tumors Less << Phase 3 Completed - Netherlands ... More >> The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands, 1066 CX Leiden University Medical Centre (LUMC) Leiden, Netherlands, 2300 RC Less <<
NCT01793636 Metastatic Clear Cell Renal Ca... More >>rcinoma Less << Phase 2 Terminated(Inferior efficacy o... More >>f study drug in renal indication.) Less << November 2015 United Kingdom ... More >> Royal Bournemouth Hospital Bournemouth, United Kingdom, BH7 7DW Royal Sussex County Hospital Brighton, United Kingdom, BN2 5BE University Hospitals Coventry & Warwickshire NHS Trust Coventry, United Kingdom, CV2 2DX Beatson West of Scotland Cancer Center Glasgow, United Kingdom, G12 0YN St. James' Hospital Leeds, United Kingdom, LS9 7TF Barts Health NHS Trust London, United Kingdom, EC1A 6BE Royal Free London Hospital London, United Kingdom, NW3 2QG Southampton General Hospital Southampton, United Kingdom, SO16 6YD Southend University Hospital NHS Foundation Trust Westcliff-On-Sea, United Kingdom, SS0 0RY Less <<
NCT00923130 Renal Cell Carcinoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, South Carolina University of South Carolina Charleston, South Carolina, United States, 29425 Less <<
NCT01700699 - Unknown October 2013 Italy ... More >> Department of Medicine and Surgery, Univeristy of Salerno Recruiting Baronissi, Salerno, Italy, 84081 Contact: Mario Vitale, MD    +39 089672539    mavitale@unisa.it    Principal Investigator: Mario Vitale, MD Less <<
NCT01714765 Metastatic Clear Cell Renal Ca... More >>ncer Less << Phase 1 Completed - United Kingdom ... More >> Barts Health NHS Trust London, United Kingdom, EC1M 7BE Less <<
NCT00767819 Progressive Sarcoma Phase 2 Completed - Germany ... More >> Novartis Investigative Site Bad Saarow, Germany, 15526 Novartis Investigative Site Duesseldorf, Germany, 40479 Novartis Investigative Site Essen, Germany, 45147 Novartis Investigative Site Mannheim, Germany, 68167 Novartis Investigative Site Muenchen, Germany, 81377 Italy Novartis Investigative Site Milano, MI, Italy, 20133 Less <<
NCT03598816 Renal Cell Carcinoma Phase 2 Not yet recruiting November 30, 2021 United States, Missouri ... More >> Washington University School of Medicine Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: James J Hsieh, M.D., Ph.D.    314-273-1688    jhsieh@wustl.edu    Principal Investigator: James J Hsieh, M.D., Ph.D.          Sub-Investigator: Vivek Arora, M.D., Ph.D.          Sub-Investigator: William E Gillanders, M.D.          Sub-Investigator: Eric Knoche, M.D.          Sub-Investigator: Jingqin (Rosy) Luo, Ph.D.          Sub-Investigator: Peter Oppelt, M.D.          Sub-Investigator: Russell Pachynski, M.D.          Sub-Investigator: Joel Picus, M.D.          Sub-Investigator: Bruce Roth, M.D.          Sub-Investigator: Malachi Griffith, Ph.D.          Sub-Investigator: Obi Griffith, Ph.D. Less <<
NCT01649180 - Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << - -
NCT02533258 - Completed - -
NCT02533258 - Completed - -
NCT01105364 Kidney Cancer ... More >> Metastatic Cancer Less << Not Applicable Unknown - France ... More >> Centre Hospitalier Universitaire Bretonneau de Tours Recruiting Tours, France, 37044 Contact: Contact Person    33-2-4747-4776 Less <<
NCT01649180 Renal Cell Carcinoma Phase 2 Terminated(Closed due to prolo... More >>nged enrollment timelines) Less << - United States, Nebraska ... More >> Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, Ohio Cleveland Clinic, Taussig Cancer Institute Cleveland, Ohio, United States, 44195 United States, Pennsylvania University of Pennsylvania, Abramson Cancer Center Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT02048371 Liposarcoma O... More >>steogenic Sarcoma Ewing/Ewing-like Sarcoma Rhabdomyosarcoma Less << Phase 2 Recruiting December 2020 United States, California ... More >> City of Hope National Medical Center Recruiting Duarte, California, United States, 91010 Contact: Torie Fechner    626-256-4673    tfechner@coh.org    Principal Investigator: Warren Chow, MD          Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Magnolia Manzano    323-361-8156    mmanzano@chla.usc.edu    Sarcoma Oncology Research Center Recruiting Santa Monica, California, United States, 90403 Contact: Victoria Chua    310-552-9999    vchua@sarcomaoncology.com    Principal Investigator: Sant Chawla, MD          Stanford University Recruiting Stanford, California, United States, 94305 Contact: Maria Ahern    650-725-6413    mahern@stanford.edu    Principal Investigator: Kristen Ganjoo, MD          United States, Florida Mayo Clinic - Florida Recruiting Jacksonville, Florida, United States, 32224 Contact: Steven Attia, DO    904-953-7292    Attia.Steven@mayo.edu    Principal Investigator: Steven Attia, DO          H. Lee Moffitt Terminated Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Rasima Cehic    312-695-2082    rasima.cehic@northwestern.edu    Principal Investigator: Mark Agulnik, MD          United States, Indiana Indiana University Recruiting Indianapolis, Indiana, United States, 46202 Contact: Michele Niland    317-278-0778    mniland@iupui.edu    Principal Investigator: Daniel Rushing, MD          United States, Massachusetts Dana Farber/Partners Cancer Care Terminated Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic - Minnesota Recruiting Rochester, Minnesota, United States, 55905 Contact: Elizabeth Smith    507-293-3817    Smith.Elizabeth6@mayo.edu    Principal Investigator: Scott Okuno, MD          United States, North Carolina Carolinas Healthcare System Recruiting Charlotte, North Carolina, United States, 28203 Contact: Michelle Treadwell    980-442-2332    Michelle.Treadwell@carolinashealthcare.org    Principal Investigator: Michael Livingston, MD          Duke University Recruiting Durham, North Carolina, United States, 27705 Contact: Colleen Piechocki    919-681-1883    colleen.piechocki@duke.edu    Principal Investigator: Richard Riedel, MD          United States, Ohio Ohio State University Recruiting Columbus, Ohio, United States, 43202 Contact: Comprehensive Cancer Center    800-293-5066    Jamesline@osumc.edu    Principal Investigator: David Liebner, MD          United States, Oregon Oregon Health and Science University Recruiting Portland, Oregon, United States, 97239 Contact: David Boody-Alter    503-418-9655    boodyalt@ohsu.edu    Principal Investigator: Lara Davis, MD          United States, Tennessee Vanderbilt University Recruiting Nashville, Tennessee, United States, 37232 Contact: Melissa Sindler    615-875-0060    melissa.m.sindler@vanderbilt.edu    Principal Investigator: Vicky Keedy, MD          United States, Utah Huntsman Cancer Institute Recruiting Salt Lake City, Utah, United States, 84112 Contact: Justin Parker    801-587-4702    justin.parker@hci.utah.edu    Principal Investigator: Jennifer Wright, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Roxanne Moore    206-288-6425    romoore@seattlecca.org    Principal Investigator: Elizabeth Loggers, MD, PhD Less <<
NCT02616185 Prostatic Neoplasms Phase 1 Recruiting March 15, 2021 United States, Connecticut ... More >> Smilow Cancer Hospital at Yale-New Haven Recruiting New Haven, Connecticut, United States, 06510 United States, Maryland National Institutes of Health Active, not recruiting Bethesda, Maryland, United States, 20892-1196 National Institutes of Health Clinical Center Active, not recruiting Bethesda, Maryland, United States, 20892 United States, Nebraska GU Research Network Recruiting Omaha, Nebraska, United States, 68130 United States, Nevada Comprehensive Cancer Centers of Nevada Recruiting Las Vegas, Nevada, United States, 89169 United States, New York Memorial Sloan-Kettering Cancer Center 53rd Street Recruiting New York, New York, United States, 10022 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center, Sidney Kimmel Center Recruiting New York, New York, United States, 10065 Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Recruiting Durham, North Carolina, United States, 27710 Investigational Chemotherapy Services Recruiting Durham, North Carolina, United States, 27710 United States, Pennsylvania UPMC Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 UPMC CancerCenter- Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 University of Washington Medical Center Recruiting Seattle, Washington, United States, 98195 Less <<
NCT00640692 - Terminated(Insufficient enroll... More >>ment) Less << April 2011 -
NCT02342600 Gastrointestinal Stromal Tumor... More >>s Less << Phase 2 Withdrawn(Supporting company w... More >>ithdrew interest) Less << - -
NCT03171389 GIST, Malignant ... More >> KIT Exon 13 Mutation KIT Gene Mutation Less << Phase 2 Recruiting September 22, 2020 Germany ... More >> West German Cancer Center Recruiting Essen, NRW, Germany, 45122 Principal Investigator: Sebastian Bauer, Prof. Dr. Less <<
NCT02071719 - Terminated October 2017 Netherlands ... More >> VU Medical Center Amsterdam, Noord Holland, Netherlands, 1081 HV Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.88mL

0.38mL

0.19mL

9.39mL

1.88mL

0.94mL

18.78mL

3.76mL

1.88mL

References

[1]Shukla S, Robey RW, et al. Sunitinib (Sutent, SU11248), a small-molecule receptor tyrosine kinase inhibitor, blocks function of the ATP-binding cassette (ABC) transporters P-glycoprotein (ABCB1) and ABCG2. Drug Metab Dispos. 2009 Feb;37(2):359-65.

[2]Sun L, Liang C, et al. Discovery of 5-[5-fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl] -2,4- dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide, a novel tyrosine kinase inhibitor targeting vascular endothelial and platelet-derived growth factor receptor tyrosine kinase. J Med Chem. 2003 Mar 27;46(7):1116-9.

[3]Mendel DB, Laird AD, et al. In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res. 2003 Jan;9(1):327-37.

[4]Zhou Q, Gallo JM. Differential effect of sunitinib on the distribution of temozolomide in an orthotopic glioma model. Neuro Oncol. 2009;11(3):301-10.

[5]sunitinib malate

[6]Blasi E, Heyen J, et al. Sunitinib, a receptor tyrosine kinase inhibitor, increases blood pressure in rats without associated changes in cardiac structure and function. Cardiovasc Ther. 2012 Oct;30(5):287-94.

[7]Gotink KJ, Broxterman HJ, et al. Acquired tumor cell resistance to sunitinib causes resistance in a HT-29 human colon cancer xenograft mouse model without affecting sunitinib biodistribution or the tumor microvasculature. Oncoscience. 2014 Dec 15;1(12):844-53. eCollection 2014.

[8]Sutent

 

Historical Records

Categories